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ABSTRACT 
Synthetic Complexes of Relevance to Ni(II)-Containing Enzymes 
 
by 
Katarzyna Rudzka, Doctor of Philosophy 
Utah State University, 2008 
 
Major Professor: Dr. Lisa M. Berreau 
Department: Chemistry and Biochemistry 
The work outlined herein presents an investigation of synthetic model complexes 
of relevance to the active sites of Ni(II)-containing enzymes, particularly urease, 
glyoxalase I, and acireductone dioxygenase. The research focuses on studying the 
structural and reactivity features of nickel complexes with biologically relevant 
substrates.       
The anion of acetohydroxamic acid is a well-known inhibitor of urease enzymes, 
including those isolated from Klebsiella aerogenes and Bacillus pasteurii. A precursor to 
the acetohydroxamate coordination in ureases is proposed to be an interaction between 
Ni(II) and acetohydroxamic acid. By using a novel supporting chelate ligand capable of 
secondary hydrogen bonding interactions a novel pseudo-octahedral, Ni(II) 
acetohydroxamic acid complex has been isolated and characterized. Detailed analysis of 
the structural features and acetohydroxamic displacement reactivity of this complex has 
provided fundamental chemical insight toward understanding of the inhibition 
mechanism in urease enzymes. 
 iv
Glyoxalase I (Glx I) catalyzes one step of the cellular detoxification pathway for 
α-ketoaldehydes (e.g. methylglyoxal) in humans and bacteria. The GlxI enzyme from E. 
coli is a Ni(II)-containing enzyme that catalyzes the isomerization of a hemithioacetal to 
produce a thioester. Of relevance to this enzyme, the first example of a Ni(II) complex 
that promotes a hemithioacetal isomerization is reported herein. In order to monitor this 
type of reaction a new approach involving a a deuterium-labeled hemithioacetal  
(PhC(O)CH(OH)SCD3) and 2H NMR was employed.  
Acireductone dioxygenases (ARDs) catalyze aliphatic oxidative C-C bond 
cleavage of an acireductone (1,2-dihydroxy-3-oxo-5-(methylthio)pent-1-ene) 
intermediate in the methionine salvage pathway. A unique aspect of these enzymes is that 
the regioselectivity of the dioxygenase reaction depends on the metal ion bound in the 
active site. Outlined herein are descriptions of the synthesis, characterization, and O2 
reactivity of a novel trinuclear Ni(II) enediolate complex of relevance to the proposed 
enzyme/substrate adduct in Ni(II)-ARD.   
Efforts have also been made toward the preparation of  C(1)-H acireductone 
compounds using a combined synthetic/enzymatic approach. A phenyl appended-C(1)-H 
acireductone was isolated and introduced to a Ni(II) precursor complex. This reaction 
produced spectroscopic changes consistent with the formation of a new Ni(II) 
acireductone complex. Preliminary studies of the O2 reactivity of this complex are 
reported. 
(170 pages) 
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CHAPTER 1 
INTRODUCTION 
 
The Coordination Chemistry of Nickel(II) 
 The coordination chemistry of nickel spans a variety of geometries, coordination 
numbers, and oxidation states.1 Nickel complexes are known with oxidation states 
ranging from -1 to +4. However, the most common oxidation state is Ni(II) ([Ar]3d8). 
The majority of early coordination chemistry work focused on Ni(II) complexes, 
although recent interest toward understanding the nickel centers in redox active enzymes 
has shifted attention to less common oxidation states (-1, 0, +1, +3 and +4). Ni(II) forms 
a large number of complexes with a coordination number of 4, 5 or 6, and their 
geometries include all major structural types. With regard to Lewis acidity, Ni(II) is 
considered to be a borderline metal ion. This is because it binds to both soft and hard 
ligands and sometimes, albeit rarely, to both in the same complex.1 Table 1-1 summarizes 
the information on the oxidation states and geometries that are common for Ni(II) 
complexes as well as examples from the literature.  
 
Table 1-1. Oxidation States and Stereochemistry of Nickel(II) complexes.2 
 
Oxidation 
State 
Coordination 
number Geometry Examples 
Square planar NiBr2(PEt3)2, [Ni(CN)4]2- 
4 
Tetrahedral [NiCl4]2-, NiCl2(PPh3)2 
Square pyramidal (sp) [Ni(CN)5]3-, [Ni2Cl8]4- 
5 Trigonal bipyramidal 
(tbp) 
[Ni(CN)5]3-, 
Ni(SiCl3)2(CO)3 
Ni(II), d8 
6 Octahedral Ni(NH3)62+, [Ni(bipy)3]2+ 
 2
Nickel in Biological Systems 
 
  Nickel is found in the active site of eight metalloenzymes.3 Of this group, nickel 
is redox active in carbon monoxide dehydrogenase, acetyl-CoA synthase, iron-nickel 
hydrogenase, superoxide dismutase and methyl coenzyme M reductase. For the other 
three enzymes (urease, glyoxalase I, and acireductone dioxygenase) the oxidation state of 
the nickel center is +2 and does not change during catalysis. Instead the nickel center(s) 
in these enzymes is/are proposed to be a Lewis acid that coordinates and facilitates 
deprotonation of a substrate (or inhibitor), or lowers the pKa of water to produce a Ni(II)-
OH species. The following sections provide additional details about the current state of 
knowledge of these enzymes and relevant model studies. 
 
Ni(II)-containing Enzymes with no Redox Activity 
 
The role of nickel ions in the catalytic mechanism of  urease 
The isolation and crystallization of urease was the culmination of nearly a century 
of lasting endeavor to purify the enzyme. It was the very first enzyme to be isolated and 
crystallized in 1926 in research performed by the Nobel Prize winner James B. Sumner. 
However, the enzyme was not shown to contain nickel in its active site until fifty years 
later. Before this discovery, nickel was considered to be a toxic element with no specific 
biological role. 
Urease is produced by plants, algae, fungi, and bacteria, and catalyzes the 
hydrolytic decomposition of urea. It is important to note that urea spontaneously 
decomposes in water producing cyanic acid and ammonia, however at 38 oC this reaction 
proceeds with a half life of ~3.6 years (Scheme 1-1, (A)).4 The unusually high hydrolytic 
 3
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Scheme 1-1. (A) Reaction scheme for uncatalyzed urea hydrolysis; (B) Reaction scheme 
for the urease-catalyzed urea hydrolysis.  
 
stability of urea is presumably caused by its high resonance stabilization energy (ca. 30-
40 kcal/mol).5 This energy can be significantly reduced upon binding of urea to a nickel 
center of the urease enzyme. The enzymatic reaction results in the formation of ammonia 
and carbamic acid, the latter of which spontaneously decomposes at physiological pH to 
give a second molecule of ammonia and bicarbonate (Scheme 1-1, (B)).  Urease is a 
highly efficient enzyme, with a kcat/Km value approximately 1014 times higher than the 
rate of the uncatalyzed reaction.6 Other alternative substrates, such as acetamide, N-
methylurea, or semicarbazide can also be utilized by urease, although with lower rates of 
hydrolysis (kcat values ~102-103-fold lower).4 
Several X-ray structures of ureases have been deposited in the Protein Data Bank 
(PDB). There are structures of the native proteins isolated from a variety of bacterial 
organisms, as well as urease mutants and ureases complexed with small molecules.7  
The active site of the enzyme (Figure 1-1) contains two nickel ions bridged by a 
carbamylated lysine and a hydroxide ion. It has been confirmed that carbon dioxide is 
 4
required for the binding of nickel to urease.8 Upon the reaction with carbon dioxide, the 
lysine residue is converted into the carbamate, which captures the nickel ions in the 
active site. Each nickel additionally coordinates two histidine residues and a water 
molecule. The coordination sphere of Ni(2) is filled by an additional terminally bound 
aspartate resulting in a pseudo-octahedral environment. The other nickel ion (Ni(1)) has a 
vacant coordination site and a distorted square pyramidal geometry.9  
Due to its nickel content, urease is a unique example among the hydrolytic 
enzymes, which typically contain zinc as the essential cofactor. In this context, the 
question of the role of nickel in the catalytic mechanism remains intriguing for the 
bioinorganic community. An approach toward addressing this issue has involved attempts 
to substitute nickel with other divalent metal ions, such as Zn2+, Co2+, and Mn2+.7 
Removal of both Ni2+ ions by treating the enzyme with EDTA at low pH causes 
irreversible denaturation of the protein.10 Removal of a single Ni2+ ion by dialysis in the 
presence of citrate was reported, indicating that the two metal ions are bound with 
 
  
Ni(1)
NHN
His
N
HN
His
Ni(2)
O O
NH
Lys
O
OH2 OH2
N
N
H
N
His
NH
His
O
AspO
H
 
Figure 1-1. Schematic representation of the active site of urease. 
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different affinities.10 These findings can be interpreted on the basis of the active site 
structure in which Ni(2) is six-coordinate while Ni(1) is ligated only by five residues.  
The more labile metal ion can be substituted with Zn2+ or Co2+ using long term dialysis. 
The mixed-metal derivatives, as well as the single-Ni2+ protein, are catalytically inactive, 
indicating that the presence of both nickel ions is essential for the hydrolysis reaction. 
High-resolution X-ray structures of native ureases (PDB entries: 1FWJ and 2UBP) and 
the structures of enzymes complexed with either a substrate analog (1S3T) or inhibitor 
(1IE7), have enabled researchers to propose a mechanistic pathway for the enzymatic 
hydrolysis of urea.7 In the proposed mechanism, the carbonyl oxygen of urea binds to the 
coordinatively unsaturated Ni(1) with displacement of a water molecule (Scheme 1-2). 
Nucleophilic attack by the Ni(2)-terminal hydroxide at the sp2 carbon atom of urea yields 
a tetrahedral transition state. Protonation of the leaving group is the driving force for the 
urea C-N bond breakage and the release of ammonia.11  
Many ureolytic microorganisms contribute to the development of various human 
disorders, such as the formation of urinary stones and gastric ulceration.12 In addition,  a 
high activity of soil ureolytic microorganisms can have negative effects in agriculture 
decreasing the efficiency of urea fertilizers.13 Due to its harmful role in medicine and 
agriculture, urease is a target for inhibitory studies. Several classes of molecules have 
been tested as competitive inhibitors for these enzymes, including acetohydroxamic acid 
(AHA).13,14  It has been suggested that AHA initially binds to the active site of urease (B. 
pasteurii and K. aerogenes) as a neutral molecule resulting in formation of a weak 
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Scheme 1-2. The proposed catalytic mechanism for the enzymatic hydrolysis of urea 
based on X-ray crystallographic data.15 
 
enzyme/inhibitor (E-I) complex (Scheme 1-3).13,16,17 The coordination of the neutral 
inhibitor to Ni(1) may be assisted  by a hydrogen bonding interaction between the 
bridging hydroxide and the hydroxyl group of AHA. This E-I complex is then proposed 
to slowly convert to a more stable E-I* structure in which the negatively charged 
hydroxamate OB oxygen bridges the two Ni ions. The carbonyl oxygen is bound to Ni(1) 
to form a five-membered chelate ring. X-ray structures of ureases complexed with 
acetohydroxamate (AH-) isolated from B. pasteurii 16 (4UBP) and K. aerogenes 
17(1FWE) have been reported. 
 
 
 
 7
Synthetic models for the active site of urease 
 Many aspects of the catalytic pathway of urease are still under debate. Recent 
synthetic modeling studies employ well-designed nickel complexes to address questions 
about the mode of urea binding, the exact identity of the nucleophile and the mechanism 
of the urease-catalyzed reaction. Despite the report of several model complexes for 
urease, none of them is capable of mediating the direct hydrolytic degradation of urea.5 
The only synthetic compound with urease-like activity promotes the slow ethanolysis of 
urea to give four equivalents of ethyl carbamate after 12 h at 80 oC (Figure 1-2).18 
However a fully functional model complex for urease is not yet available.  
 In efforts to elucidate the inhibition process in the urease system, a number of 
Ni(II) complexes of acetohydroxamate derivatives have been reported.19-22 One of the 
synthetic models that reveals the coordination of AH- to the dinickel site is presented in 
Figure 1-3.19 The acetohydroxamate moiety features a bridging coordination mode akin 
to the acetohydroxamate-inhibited urease. 
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Scheme 1-3. The conversion of a weak enzyme/inhibitor complex (E-I) into a stable 
complex of urease and hydroxamate (E-I*).  
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Figure 1-2. Drawing of the cationic portion of [Ni2(Me4tpdp)(OAc)(urea)]2+.18 
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Figure 1-3. Drawing of the cationic portion of the dinuclear Ni(II) complex 
[Ni2(OAc)2(CH3(O)NH(O)(urea)(tmen)2]+.19 
 
Glyoxylase I and its contribution to cellular detoxification 
Glyoxalase I catalyzes a key step of the cellular detoxification pathway for α-
ketoaldehydes in bacteria, animals and humans.23 The first step of this pathway is a non-
enzymatic reaction of the α-ketoaldehyde (e.g. methylglyoxal (MG)) and glutathione 
(GSH) which results in the formation of a hemithioacetal (Scheme 1-4). Glyoxalase I 
(GlxI) catalyzes the isomerization of the hemithioacetal to a thioester product. 
Subsequently, the glyoxalase II enzyme (GlxII) promotes the hydrolysis of the thioester, 
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producing the corresponding α-hydroxy acid and GSH. These two enzymes are referred 
to as the glyoxalase system.  
 Due to their electrophilic nature, α-ketoaldehydes tend to form adducts with 
nucleic acids as well as certain protein residues, leading to deleterious effects in cells. 
The consequences of MG cellular accumulation include lipid modification, oxidative 
damage, the inhibition of protein and RNA synthesis, and increased apoptosis.24,25 
Additionally, methylglyoxal as well as other 1,2-dicarbonyl compounds are often 
responsible for non-enzymatic, irreversible glycation of amino acids.26  The glycation 
reaction, followed by a number of rearrangements, dehydration and redox reactions, leads 
to the formation of advanced glycation end products (AGEs). AGEs are associated with 
the chronic complications of diabetes mellitus and have been reported to play an 
important role in the pathogenesis of Alzheimer’s disease.27 Inhibition of GlxI results in 
elevated levels of MG that can be lethal for cells. Notably, this toxicity can be utilized in 
the design of anticancer and antimalarial agents with a number of small molecule 
inhibitors of human glyoxalase I having been described in the literature.28-30 
 
  
Scheme 1-4. The reactions catalyzed by the glyoxalase system. 
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 Two distinct classes of GlxI enzymes have been identified to date.31 A zinc-
dependent glyoxalase I (e.g. human and rat liver GlxI) is a prevalent form of the enzyme 
and has been extensively studied. However more recent studies revealed that various 
bacterial GlxI enzymes exhibit maximal activity in the presence of Ni 2+ (E. coli 32,33, as 
well as Y. pestis, P. aeruginosa, and N. meningitis31). GlxI from the human parasite L. 
major was also found to be Ni-dependant.34 
 X-ray crystallographic studies have shown that the active site of the Ni2+-
containing GlxI enzyme from E. coli possesses a distorted octahedral geometry, with the 
metal ion being ligated by two histidine residues, two glutamates, and two water 
(hydroxide) molecules (Figure 1-4).35,36 Interestingly, the zinc-substituted form of the 
enzyme was found to have a different geometry around the metal center, specifically  
the five-coordinate zinc has all of the amino acid ligands found in Ni2+ GlxI but only one 
water (hydroxide) ligand.23 A correlation between catalytic activity and the coordination 
number at the metal binding site has been found.36 The E. coli enzyme containing Zn2+ as 
the metal cofactor is inactive, therefore it has been concluded that an octahedral geometry 
is a prerequisite for activity in that enzyme. 
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Figure 1-4. (Left) Drawing of the active site of E. coli glyoxalase I, (right) drawing of 
the active site of Zn-dependent GlxI.  
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The proposed mechanisms for Ni(II)-dependent  
glyoxalase I-catalyzed hemithioacetal isomerization 
 
Based on spectroscopic studies of product- and inhibitor bound forms of the E. 
coli enzyme, the catalytic reaction is proposed to involve the formation of a nickel 
hydroxide species. This nickel hydroxide can serve as a general base to promote a proton 
abstraction from the hemithioacetal substrate (Scheme 1-5). Extended X-ray absorption 
fine structure (EXAFS) and X-ray absorption near-edge spectroscopy (XANES) studies 
of the Ni2+ enzyme showed that the first coordination sphere of the metal center remains 
unchanged upon addition of  substrate.37 Hence the enediolate intermediate generated by 
the deprotonation of the hemithioacetal presumably is not coordinated to the Ni(II) center 
in the course of the reaction. The enediolate anion is subsequently protonated at the 
former carbonyl carbon to yield the thioester product.  
Another interesting mechanistic hypothesis has been formulated following the 
inspection of the human Zn 2+ glyoxalase co-crystallized with S-(N-hydroxy-N-p-
iodophenylcarbamoyl)gluthatione (HIPC-GSH, Figure 1-5).38 HIPC-GSH is a transition 
state analogue. In the X-ray structure, the hydroxycarbamoyl function is directly 
coordinated to the active site zinc ion. X-ray crystallography also revealed the 
displacement of one of the glutamate residues from the metal center; hence this residue 
was postulated to play the role of the general base in the mechanistic pathway. 
Based on EXAFS studies, a similar displacement was suggested for the E. coli 
Ni2+ enzyme complexed with a acetohydroxamate derivative of gluthiatione (Figure 1-
6).39 However, the differences in metal binding affinities of hydroxamate derivatives and 
the enediolate intermediate might question the idea that hydroxamates are accurate  
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Scheme 1-5. Proposed mechanism for E. coli glyoxalase I.37 
 
models for enediolate binding. As a consequence, caution is required in interpreting these 
studies.23   
 Given the lack of a clearly defined general base in the GlxI reaction pathway, the 
synthetic modeling studies come to play an important role in elucidation of mechanistic 
questions. Due to the fact that mononuclear Ni(II)-OH complexes remain scarce in the 
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literature, these investigations are rather challenging. To date, only one mononuclear 
Ni(II)-OH has been characterized, although it has not been shown to promote the 
isomerization of hemithioacetal of relevance to the GlxI reaction.40 
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Figure 1-5. (Left) S-(N-hydroxy-N-p-iodophenylcarbamoyl)glutathione (HIPC-GSH); 
(Right) Drawing of the active site of human GlxI complexed with HIPC-GSH.  
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Figure 1-6. L-glutamyl-N-methyl-L-glutaminglycine. 
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Ni(II)-dependent  acireductone dioxygenase 
 in the methionine salvage pathway 
 
 Acireductone dioxygenase (ARD) enzymes are associated with the methionine 
salvage pathway (MSP), a ubiquitous biological cycle.41 ARDs catalyze oxygen-
dependent aliphatic C-C bond cleavage in 1,2-dihydroxy-3-oxo-5-(methylthio)pent-1-ene 
(acireductone). Over-expression of the ARD gene in E. coli produces two ARD enzymes, 
one containing Fe2+ and a second containing Ni2+ as the metal cofactor.42 A unique 
feature of the reactions catalyzed by these enzymes is that the regioselectivity of the 
carbon-carbon bond cleavage depends on the metal ion bound in the active site. While 
Ni2+-ARD catalyzes a reaction that is a shunt out of the methionine salvage pathway, 
Fe2+-ARD operates on-pathway enabling the recovery of methionine (Scheme 1-6).42-44 
The Ni2+-ARD reaction gives as products methylthiopropionic acid, formate and carbon 
monoxide. None of these products is a precursor for methionine, and more importantly 
methylthiopropionic acid is cytotoxic.45Alternatively, carbon monoxide has been found to 
play a role as a neurotransmitter in mammals.46 It is proposed that the activity of Ni2+-
containing ARD might aid in the regulation of methionine levels, however the precise 
function of this enzyme is still unclear.47 Fe-ARD converts the acireductone intermediate 
to an α-ketoacid that is a precursor for methionine, and formate. Interestingly, the 
oxidative breakdown of an acireductone proceeds also under non-enzymatic conditions, 
resulting in the formation of the same products as the reaction catalyzed by iron-
containing ARD.44  
 Methionine, apart from being an essential amino acid in the human diet, is also an 
important intermediate in biosynthetic pathways.41 S-Adenosyl methionine (SAM), a 
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Scheme 1-6. Methionine salvage pathway (MSP).41 
 
coenzyme involved in methyl group transfer reactions, is formed enzymatically from  
adenosine triphosphate (ATP) and methionine, and plays a critical role in numerous 
metabolic methylations (e.g. DNA methylation). SAM is also a source of the 
aminopropyl group for the syntheses of polyamines (spermidine and spermine) which are 
associated with the cell cycle and cell growth.48 The byproduct of aminopropyl transfer is 
methylthioadenosine (MTA), a potent regulatory metabolite that affects both polyamine  
synthesis and transmethylation reactions.49 A subsequent breakdown of the MTA 
molecule proceeds via multiple steps of methionine salvage pathway and provides the 
carbon skeleton as well as the thiomethyl group for methionine regeneration. The MTA 
breakdown leads to the formation of an acireductone intermediate that is the substrate for  
both nickel- and iron-containing ARD enzymes and represents a branch point in the  
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MSP.41  
 Ni2+- and Fe2+-containing acireductone dioxygenases are monomeric enzymes 
that have an identical amino acid sequence. Hence, the only chemical difference between 
them is the nature of the metal cofactor.50 The fact that nickel- and iron-containing ARDs 
can be separated using hydrophobic interaction and strong anion exchange 
chromatography columns suggests that significant structural differences exist between 
these two isoforms. These two enzymes can be interconverted by metal removal and 
reconstitution with the other metal ion. The ARD protein binds Ni2+ more tightly than 
Fe2+, as demonstrated by the fact that Fe2+ can be removed from the folded enzyme by 
dialysis against EDTA, whereas removal of Ni2+ requires the protein to be unfolded.42 
Furthermore, addition of apo-ARD to an equimolar mixture of Fe2+ and Ni2+ produced 
>80% of the Ni-containing form within one minute, indicating a substantial preference 
for Ni2+ binding over Fe2+.42  Attempts to reconstitute ARD with other metal ions have 
been also reported.51 Ni2+-type reactivity is exhibited by Co2+ or Mn2+ containing ARD 
analogs, and Mg2+-ARD exhibits reduced Fe2+-type activity. 
 
Structural features of Ni2+-ARD 
 To date, the only crystallographic structure of an ARD enzyme deposited in the 
Protein Data Bank does not provide information about the identity of the metal ion in the 
active site (ARD mouse homolog, PDB entry 1VR3).52 Therefore, the proposed structural  
features of nickel-containing ARD are based on X-ray absorption spectroscopy (XANES 
and EXAFS), NMR studies (PDB entries 1M40 and 1ZRR) and homology modeling.41 
XAS experiments revealed a pseudo octahedral geometry for the Ni2+ ion in the ARD  
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Figure 1-7. (Left) Primary coordination environment of the active site of Ni2+-ARD. 
(Right) Secondary environment; residues within 8 Å from the Ni2+ center (PDB entry 
1ZRR).53 
 
active site, with six N/O donor ligands, at least three of which are histidine imidazole  
nitrogens.47 Due to the paramagnetic nature of Ni2+ the 1H NMR resonances of residues 
within 9 Å of the metal center  are broad and significantly shifted (45-75 ppm) region. 
These signals are assigned to imidazole protons of the histidine ligands.54 NMR studies 
together with conserved domain homology modeling (based on the structure of jack bean 
canavalin) were used to predict a structure of the Ni2+-ARD active site. Figure 1-7 (left) 
shows the primary coordination environment of the nickel-containing ARD.53 The Ni2+ 
center is ligated by three histidine residues (His 96, 98, and 140) and one glutamate (Glu 
102). Two water molecules complete the Ni2+ coordination sphere. The secondary 
environment (Figure 1-7 (right)) consists of hydrophobic (Phe142, Phe92, Trp162) as 
well as hydrogen-bond donor residues (Arg104, Arg154). It is proposed that these 
secondary residues influence the positioning of the substrate in the active site. 
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Mechanistic studies of the reaction  
catalyzed by Ni2+-containing ARD 
 
 The acireductone substrate (1,2-dihydroxy-3-oxo-5-(methylthio)pent-1-ene, 
(Figure 1-8 (A)) belongs to a class of compounds called reductones. These compounds 
contain an enediol functionality stabilized by conjugation and hydrogen bonding with an 
adjacent carbonyl group (RC(OH)=C(OH)C(=O)R). They are strong reducing agents and 
fairly strong acids (e.g. ascorbic acid).55 To date, a synthetic route for the native ARD 
substrate has not been reported. However, straightforward syntheses of analogs have been 
described in the literature (Figure 1-8, (B)-(D)).56 These analogs have been proven to 
serve as alternative substrates for the ARD enzymes. Due to their acidic nature, 
acireductones exist as singly deprotonated species in aqueous solutions at physiological 
pH.50 
 Structural, spectroscopic, and mechanistic studies reported to date have enabled 
the formulation of a proposed mechanistic pathway for the reaction catalyzed by nickel-
containing ARD (Scheme 1-7).50 Based on the identification of a UV-vis spectral shift 
upon substrate binding to the active site, it was concluded that the substrate coordinates 
to Ni2+ as a dianion in the anaerobic ES complex. The binding of the substrate results in 
the loss of two-coordinated ligands (either the two water molecules (Scheme 1-7) or one 
water molecule and His98 (as previously proposed47)). In the anaerobic ES complex, the 
acireductone is believed to bind in 1,3-coordination mode.  
 Coordination of the substrate to Ni2+ is followed by electron transfer from the 
doubly deprotonated acireductone to O2 and subsequent binding of peroxide at the C-1  
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Figure 1-8. (A) 1,2-dihydroxy-3-oxo-5-(methylthio)pent-1-ene (acireductone, native 
substrate for ARD enzymes); (B)-(D) Synthetic acireductone analogs (proven to serve as 
substrates for ARD enzymes).  
 
carbon of the substrate. Rearrangement of this species gives rise to a five-membered 
cyclic peroxide intermediate, which breaks down to produce formate, carbon monoxide 
and methythiopropionate. In order to confirm this mechanistic proposal, 18O2  labeling 
experiments were performed.50 This revealed the incorporation of one oxygen atom into 
each carboxylate product (Scheme 1-7, bold face oxygen atoms represent the result of 
isotopic labeling studies). In the case of iron-containing ARD, acireductone is proposed 
to bind to the metal center and interact with O2 to produce a four-membered peroxide 
ring.54 As a result, the products of the oxidative C-C bond cleavage reaction in Fe2+-ARD 
differ from those of the Ni2+-catalyzed reaction. Specifically, in the iron-catalyzed 
reaction C(1)-C(2) bond cleavage occurs, versus C(1)-C(2) and C(2)-C(3) in the Ni2+ 
catalyzed reaction. 
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Scheme 1-8. Proposed mechanism for iron-dependent ARD reaction.54 
 21
Synthetic models for the active site of  
nickel-containing ARD 
 
 As mentioned above, the coordination mode of the acireductone molecule in the 
active site of ARD appears to trigger the distinct chemical reactions of these two 
enzymes. To investigate the possible coordination motifs of acireductone, studies of 
mononuclear Ni2+ complex with the acireductone substrate analog (2-hydroxy-1,3-
diphenylpropan-1,3-dione) were performed.57 This molecule is a sterically hindered 
model of the ARD substrate and can be conveniently prepared according to a literature 
procedure.58 Combining equimolar amounts of the 6-Ph2TPA ligand,59 Ni(ClO4)2·6H2O, 
Me4NOH·5H2O, and 2-hydroxy-1,3-diphenylpropan-1,3-dione under an inert atmosphere, 
gave a mononuclear Ni2+ complex, [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 
(Scheme 1-9). Single crystals suitable for X-ray analysis were obtained by pentane 
diffusion into a CH2Cl2 solution of complex. Based on X-ray crystallographic studies, 
this Ni2+ complex has a distorted octahedral geometry with the acireductone monoanion 
bound  in 1,3-coordination mode (Figure 1-9). This Ni2+ complex has been fully 
characterized, including by 1H NMR, and electronic absorption spectroscopy. The 1H 
NMR spectrum contains a number of relatively broad resonances characteristic of  
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Scheme 1-9. Synthesis of [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 complex. 
 22
  
Figure 1-9. (Left) ORTEP drawing of [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 
(Right) ORTEP drawing of the Ni(II) coordination environment in the cationic portion of. 
[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4. Ellipsoids are depicted at the 50% 
probability level. All hydrogen atoms except the hydroxyl proton have been omitted for 
clarity.57 Reprinted with permission from J. Am. Chem. Soc. 2005, 127, 17186. Copyright 
2005 American Chemical Society. 
 
6-Ph2TPA-Ni2+ complexes.57 The resonances in a range of 30-60 ppm have been assigned 
to β-protons of the pyridyl rings. The electronic absorption spectrum of [(6-
Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 has a distinctive feature at 399 nm (ε = 2400 
M-1cm-1).  
 This complex undergoes reaction with O2 to give a Ni2+ benzoate complex ([(6-
Ph2TPA)Ni(O2CPh)]ClO4), benzil (PhC(O)C(O)Ph), carbon monoxide and other yet 
unidentified Ph-containing species (Scheme 1-10). The oxidative aliphatic C-C bond 
cleavage within the acireductone ligand and the formation of carbon monoxide are 
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Scheme 1-10. O2 reactivity of [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4. Bold face 
oxygen atoms represent the result of isotopic labeling experiments. 
 
relevant to the reaction catalyzed by the Ni2+-containing ARD enzyme. In the absence of 
a general acid in this synthetic model system, the benzoate product remains coordinated 
to the Ni2+ center, which does not happen in the enzymatic system wherein the 
carboxylates are released from the active site. However, upon addition of acid, benzoate 
can be released from the synthetic complex.60 The Ni2+ benzoate complex ([(6-
Ph2TPA)Ni(O2CPh)]ClO4)  has been identified through independent synthesis and was 
characterized by X-ray crystallography (Figure 1-10), as well as by 1H NMR, FAB-MS, 
FTIR and elemental analysis. Results of isotopic labeling experiments performed using 
18O2 confirmed the incorporation of one oxygen atom into the Ni2+-coordinated benzoate 
product (Scheme 1-10).60 The level of 18O incorporation was found to be ~50%, as 
determined by mass spectrometry. Additionally, analysis of the headspace gas of the 
reaction shown in Scheme 1-10 using the PdCl2 method indicated the formation of CO.61 
 This mononuclear Ni2+-acireductone complex, supported by the 6-Ph2TPA ligand, 
represents an attempt to model the structural, spectroscopic and reactivity features of the 
Ni2+-ARD enzyme. There is still very little known about the precise function of ARD 
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enzymes and the mechanism of Ni2+-ARD catalyzed reaction. Despite the fact that the 
nickel- and iron-containing ARD enzymes share the same amino acid sequence, they 
catalyze distinct chemical reactions. This metal content-dependant type reactivity has not 
been identified in any other enzymatic system. Moreover, nickel-containing acireductone 
dioxygenase is the only known example of nickel-containing dioxygenase.47 
Accordingly, these features make the Ni2+-ARD enzyme an interesting candidate for 
synthetic modeling studies. 
 
   
Figure 1-10. ORTEP representation of the cationic portion of [(6-
Ph2TPA)Ni(O2CPh)]ClO4. Ellipsoids are drawn at the 50% probability level. All 
hydrogen atoms have been omitted for clarity.60 Reprinted with permission from Inorg. 
Chem. 2007, 46, 5486. Copyright 2007 American Chemical Society. 
 
 
 25
 
C N
H
O OH
R'
C C
SR
O OH
R'
C C
C
O OH
OH
R
(A) (B) (C)  
Figure 1-11. (a) Acetohydroxamic acid, (b) hemithioacetal, (c) acireductone. 
 
Summary  
 The redox inactive Ni(II)-containing enzymes described in this introductory 
chapter have in common a pseudo octahedral geometry of the active site metal center(s). 
In the dinuclear active site of urease, as well as in the mononuclear active site Ni(II) 
centers of glyoxalase I and acireductone dioxygenase, each nickel center has at least one 
open coordination site which is available for binding of a substrate or inhibitor. Several 
open questions remain regarding substrate/inhibitor binding and the subsequent reactivity 
for these metalloenzymes. For urease, the mechanism of inhibition involving 
acetohydroxamic acid (Figure 1-11(A)) is suggested to involve the formation of a weak 
enzyme/inhibitor complex, with coordination of acetohydroxamic acid to one of the two 
Ni(II) centers. This complex (designated E-I) is then proposed to undergo dehydration to 
form the hydroxamate inhibited species E-I*(Scheme 1-3). Our hypothesis concerning 
coordination of acetohydroxamic acid to a transition metal center was that hydrogen 
bonding is essential for the stabilization of such an adduct. Prior to the results presented 
herein, there were no examples of acetohydroxamic acid coordination to any transition 
metal center, thus our work, as outlined in Chapters 2 and 3, has provided the first 
structural precedent for this type of coordination.  
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 The glyoxalase system is a very intriguing target for mechanistic investigations. 
The hypothesis that we put forward is that a Ni(II)-OH or other deprotonated species is 
required for hemithioacetal isomerization. We further hypothesize that the Ni(II) center is 
involved in stabilizing a deprotonated form of the hemithioacetal substrate (Figure 1-
11(B)). As outlined in Chapter 4 we have found that a Ni(II) coordination complex 
having a deprotonated chelate ligand can promote hemithioacetal isomerization. This 
reaction proceeds more quickly and cleanly than a reaction involving a simple hydrated 
Ni(II) salt and base. Spectroscopic monitoring of these reactions has suggested possible 
deprotonated hemithioacetal coordination in the reaction involving the hydrated Ni(II) 
salt but not in the reaction promoted by the Ni(II) coordination complex.  
   With regard to the Ni(II)-dependent acireductone dioxygenase, several 
mechanistic questions remain to be addressed. UV-vis spectroscopic investigations of the 
enzyme/substrate complex suggest that the acireductone (Figure 1-11(C)) coordinates to 
the Ni(II) center as a doubly deprotonated molecule. However, the coordination mode of 
the acireductone is unknown. We decided to test the hypothesis that the coordination 
mode of the acireductone influences its reactivity with O2. A synthetic modeling 
approach, wherein Ni(II) acireductone dianion complexes are prepared, characterized, 
and studied in terms of O2 reactivity, offers the opportunity to determine structural, 
spectroscopic, and reactivity relationships. As outlined in Chapter 5 we have succeeded 
in the preparation of such a complex using 2-hydroxy-1,3-diphenylpropan-1,3-dione to 
isolate a novel Ni(II) enediolate complex. Structural, spectroscopic and reactivity studies 
of this complex are presented. Additionally, in Chapter 6 efforts to prepare a Ni(II) 
complexes of acireductones relevant to the native ARD substrate are outlined.  
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 Overall, the work outlined in this dissertation focuses on studying the 
interactions of small organic molecules (Figure 1-11) with redox-inactive Ni(II) centers 
in synthetic complexes. The results obtained provide chemical precedent on which 
biological reactions may be evaluated.  
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CHAPTER 2 
NEUTRAL ACETOHYDROXAMIC ACID COORDINATION TO  
A MONONUCLEAR NI (II) CENTER STABILIZED BY AN 
INTRAMOLECULAR HYDROGEN-BONDING INTERACTION1 
 
Abstract 
Treatment of a new chelate ligand having both amide- and phenyl-appended 
pyridyl moieties with Ni(ClO4)2•6H2O and acetohydroxamic acid in methanol solution 
results in the production of a novel pseudo-octahedral Ni(II) complex having a neutral 
acetohydroxamic acid ligand stabilized by a hydrogen-bonding interaction. 
 
Introduction 
The acetohydroxamato monoanion (AHA-) is a well-known inhibitor of several 
metalloenzymes, including urease enzymes from plants and bacteria, which contain a 
binuclear Ni(II) center within the active site.1-5 AHA- inhibition of Klebsiella aerogenes 
and Bacillus pasteurii ureases has been suggested to involve initial formation of a weak 
enzyme/inhibitor complex (E-I, Scheme 2-1) having coordination of a neutral 
acetohydroxamic acid (AHA) molecule at a single Ni(II) ion.6-8 
Stabilization of the E-I species may involve formation of a hydrogen-bonding 
interaction involving the bridging hydroxyl group.8 This E-I complex is then proposed to  
slowly convert to a more stable E-I* structure (Scheme 2-1), which exhibits a bridging 
                                                            
1 Coauthored by Katarzyna Rudzka, Magdalena M. Makowska-Grzyska, Ewa Szajna, 
Atta M. Arif, and Lisa M. Berreau. Reproduced with permission from Chem. Comm. 
2005, 489-491.  
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Scheme 2-1.  Formation of a weak enzyme/inhibitor complex with acetohydroxamic acid 
in Klebsiella aerogenes and Bacillus pasteurii ureases.  
 
coordination mode for the hydroxamate monoanion, a structural motif that has also been 
identified in model systems.9,10 In regard to the E-I species, to our knowledge, a 
structurally characterized complex having neutral acetohydroxamic acid coordination has 
not previously been reported for any transition metal ion.11 Herein we report the 
preparation and characterization of a novel synthetic mononuclear Ni(II) complex having 
a coordinated neutral acetohydroxamic acid ligand, the hydroxyl proton of which forms a 
strong hydrogen-bonding interaction with a noncoordinated pyridyl nitrogen of the 
supporting chelate ligand. 
A new chelate ligand, N,N-bis[(6-phenyl-2-pyridyl)methyl)]-N-((6-
pivaolylamido)-2-pyridyl)methyl]amine (bppppa)  having both amide-12 and aryl-
substituted pyridyl moieties was assembled as shown in Scheme 2-2. Admixture of this 
ligand with equimolar amounts of  Ni(ClO4)2•6H2O and acetohydroxamic acid in CH3OH 
solution, followed by recrystallization via Et2O diffusion into a CH3CN : CH3OH 
solution of the complex at ambient temperature resulted in the deposition of purple block 
crystals of  [(bppppa)Ni(CH3C(O)NH(OH)](ClO4)2 (1) in 72% yield. Complex 1 has been 
characterized by X-ray crystallography, elemental analysis, FTIR, UV-vis, and a solution 
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magnetic moment measurement. X-ray crystallographic analysis of 1 revealed a 
mononuclear pseudo-octahedral Ni(II) center and a tetradentate N3O-donor coordination 
mode for the bppppa chelate ligand with one phenyl-appended pyridyl moiety 
noncoordinated (Figure 2-1). The N-H and O-H hydrogen atoms of the acetohydroxamic 
acid ligand, as well as the amide N-H hydrogen of the bppppa ligand, were located and 
refined independently. Importantly, the noncoordinated pyridyl nitrogen acts as a 
hydrogen bond acceptor for the Ni(II)-coordinated hydroxyl group of the acid. This 
hydrogen bond may be classified as moderate based on the short heteroatom distance 
(O(2)-H(2)…N(5) 2.518(3) Å) and somewhat acute bond angle (158(5)º).13 A similar 
 
    
 
Scheme 2-2. Synthesis of  [(bppppa)Ni(CH3C(O)NH(OH)](ClO4)2 (1) supported by the 
(N,N-bis((6-phenyl-2-pyridyl)methyl)-N-((6-pivaloylamido)-2-pyridyl)methyl)amine) 
ligand. 
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Figure 2-1. ORTEP representation of the cationic portion of 1. All ellipsoids are drawn at 
the 35% probability level. All hydrogen atoms except the N-H and O-H protons not 
shown for clarity. Selected bond lengths (Å) and angles (º): Ni(1)-N(2) 2.027(3), Ni(1)-
N(3) 2.130(3), Ni(1)-N(4) 2.128(3), Ni(1)-O(1) 2.040(2), Ni(1)-O(2) 2.091(2), Ni(1)-
O(3) 2.037(2), O(2)-Ni(1)-O(3) 79.71(9). 
 
hydrogen-bonding interaction has been reported involving a Mn(II)-coordinated methanol 
ligand and a noncoordinated phenyl-appended pyridyl moiety in [(6-
Ph2TPA)Mn(CH3OH)3](ClO4)2 {6-Ph2TPA = N,N-bis((6-phenyl-2-pyridyl)methyl)-N-
((2-pyridyl)methyl)amine}.14 The Ni-O(H) distance involving the hydroxamic acid ligand 
is elongated in 1 by ~0.072 Å relative to that found in a structurally related pseudo-
octahedral Ni(II) hydroxamato (AHA-) complex of the 6-Ph2TPA ligand [(6 
Ph2TPA)Ni(ONHC(O)CH3)]ClO4, [2, Figure 2-2(a), Ni(1)-O(2) 2.0203(15) Å].14 The Ni-
O bond distance  involving the acetohydroxamic acid carbonyl oxygen in 1 [Ni(1)-O(3) 
2.037(2) Å) is also slightly longer than the analogous bond in 2 [1.9964(14) Å]. Within  
the hydroxamic acid/AHA- units in 1 and 2, the C-O and C-N bond distances are very 
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Figure 2-2. (a) Structure of [(6-Ph2TPA)Ni(ONHC(O)CH3)]ClO4 (2). (b) Comparison of 
core structural features of 1 and 2. 
 
similar, with the largest difference outside experimental error being ~0.005 Å in the C-N 
bond. Overall, these combined structural parameters indicate that the neutral hydroxamic 
acid binds more weakly to the mononuclear Ni(II) center in 1 than does the monoanionic 
acetohydroxamato ligand (AHA-) in 2. Finally, we note that the average Ni-O bond 
distance for 1 (2.06 Å) is slightly longer than that of 2 (2.01 Å) and the symmetric Ni-O 
distance (2.0 Å) in acetohydroxamato-inhibited urease from Bacillus pasteurii.8,14 
In regard to the structural features of 1 versus 2, it is also worth noting that the 
shorter  Ni-NPhPy distance in 1 [2.128(3) Å)] as compared to those found in 2 
[2.2630(17)/2.2292(17) Å] suggests the presence of a more Lewis acidic Ni(II) center in 
1, consistent with the coordination of the neutral acetohydroxamic ligand.  
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The solid state infrared spectra of 1 and 2 differ in several ways. For example, as 
shown in Figure 2-3 the region of 3600-3000 cm-1 for 1 contains a broader, more intense 
feature than is found for 2 under identical conditions. This is consistent with the presence 
of the additional hydroxamic acid –OH and amide NH (within the bppppa ligand) 
moieties in 1, both of which participate in hydrogen-bonding interactions. In Figure 2-4 a 
νC=O vibration can be identified at 1656 cm-1 for the Ni(II)-coordinated bppppa amide 
carbonyl group. The ν(C=O) vibration for the acetohydroxamic acid/AHA- carbonyl 
 
 
Figure 2-3. 3800-2600 cm-1 region of the infrared spectra of 1 and 2.  
 
  
 
Figure 2-4. 1700-1200 cm-1 region of the infrared spectra of 1 and 2. 
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groups in 1 and 2 should be present near 1600 cm-1. However, this region in both 
complexes is complicated by a pyridyl ring vibration, which precludes conclusive 
assignments. 
The energy of the 3A2g → 3T1g(F) and 3A2g → 3T2g(F) transitions differ in the 
electronic absorption spectra of 1 and 2 (Figure 2-5) in dry acetonitrile solution.15 The 
former transition is shifted to slightly higher energy in 1 (570 nm vs. 585 nm in 2). In 
addition, whereas in 1 the latter transition is found at ~920 cm-1, in 2 this feature is 
shifted into the near-IR region.  
 
Experimental Section 
General and physical methods. Performed as previously described.14 
 Synthesis of ligand precursors. The organic precursors 2-(pivalolylamido)-6-
(bromomethyl)pyridine,12 6-phenyl-2-pyridinecarboxyaldehyde,16 6-phenyl-2-
pyridinemethanol14 were prepared as previously reported.  
 
     
Figure 2-5. Electronic absorption spectra of 1 and 2 in dry CH3CN. The feature for 2 that 
extends into the UV range is a shoulder that is centered at ~372 nm (ε ~ 330 M-1 cm-1). 
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 (6-phenyl-2-pyridyl)methyl amine. A multistep synthetic procedure for the 
preparation of this compound from 6-phenyl-2-pyridinemethanol has been previously 
reported by Chuang et al.16 This literature procedure was followed for conversion of 6-
phenyl-2-pyridinemethanol to 2-(chloromethyl)-6-phenylpyridine hydrochloride and 
conversion of this halide derivative to 2-(phthalimidomethyl)-6-phenyl pyridine. 
However, removal of the phthalimido protecting group was achieved via treatment of 2-
(phthalimidomethyl)-6-phenyl pyridine (2.1 g, 6.5 mmol) with hydrazine monohydrate 
(0.42 g, 8.4 mmol) in ethanol (65 mL) solution. This reaction mixture was heated at 
reflux under a nitrogen atmosphere for 2 h. After cooling the solution to room 
temperature, water (45 mL) and 1M HCl were added until a pH~2 was attained. The 
resulting cloudy solution was warmed gently for 2 h. The reaction mixture was then 
allowed to cool to ambient temperature and was filtered. The yellow filtrate was treated 
with 1M NaOH until the pH~12. Extraction with CH2Cl2 (3 x 100 mL), followed by 
drying of the combined organic solutions over Na2SO4, filtration, and removal of the 
solvent under reduced pressure yielded a dark yellow oil (1.17 g, 98%). The 1H NMR 
properties of the material in CDCl3 matched those previously reported.16 
N,N-bis(6-phenyl)-2-pyridyl)methyl)-N-(((6-pivaloylamido)-2-
pyridyl)methyl)amine (bppppa). Step 1. To an ethanol solution (~5 mL) of (6-phenyl-
2-pyridyl)methyl amine (0.72 g, 3.9 mmol) was added an ethanol solution (~5 mL) of 6-
phenyl-2-pyridinecarboxyaldehyde (0.72 g, 3.9 mmol). The resulting yellow mixture was 
stirred at 45(1) °C for ~50 min. The solution was then cooled to room temperature and 
solid NaBH4 (0.16 g, 4.7 mmol) was added at which point the solution color became 
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orange. This mixture was stirred at ambient temperature for 24 h. To this solution was 
added 1 M HCl (~20 ml) until a pH~2 was reached. Following removal of all volatiles 
under reduced pressure, the resulting yellow semisolid was dissolved in CH2Cl2 (10 mL) 
and the solution was treated with 1 M NaOH until the pH > 11. The organic portion was 
removed and the aqueous fraction was extracted with Et2O (3 x 50 mL). The combined 
organic fractions were dried over excess Na2SO4, filtered, and evaporated to dryness 
yielding a brown oil (1.35 g). The major product in this oil has 1H NMR properties 
consistent with the formation of the reductive amination product N,N-bis(((6phenyl)-2-
pyridyl)methyl)amine (1H NMR (CD3CN, 400 MHz) δ 8.09-8.06 (m,  4H), 7.78 (t, J = 
7.7 Hz, 2H), 7.71 (d, J = 8.1 Hz, 2H), 7.47-7.38 (m, 6H), 7.34 (d, J = 7.7 Hz, 2H) 4.03 (s, 
4H); a N-H resonance was not identified) However, an impurity with a benzylic 
resonance at 4.71 ppm and aromatic resonances that partially overlap with the signals 
outlined above is consistently present in the product isolated using this reaction pathway. 
Thus far we have been unable to find reaction and/or column conditions that are suitable 
for the clean isolation of N,N-bis(((6-phenyl)-2-pyridyl)methyl)amine. However, the 
secondary amine product can be used in its crude form in a reaction to generate the 
bppppa ligand as described below. 
Step 2. To a CH3CN (50 mL) solution of 2-(pivaloylamido)-6-
(bromomethyl)pyridine (0.33 g, 1.2 mmol) was added crude N,N-bis-(((6-phenyl)-2-
pyridyl)methyl)amine (0.42 g, 1.2 mmol), Na2CO3 (0.50 g, 4.7 mmol) and ~5 mg of 
tetrabutylammonium bromide.  The resulting mixture was heated at reflux under nitrogen 
for ~14 h. At this point, the reaction mixture was cooled to room temperature and 1 M 
NaOH (~50 mL) was added. The organic/aqueous mixture was extracted with CH2Cl2 (3 
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x 50 mL). The combined organic fractions were dried over Na2SO4, filtered, and the 
organic solvent was removed under reduced pressure yielding a thick brown oil. This 
crude product was purified via column chromatography on silica gel (240-400 mesh, 
CH2Cl2:CH3OH 10:1, Rf = 0.62; impurity with Rf = 0.65 could not be separated). The 
final sample was isolated as a pale yellow oil (0.33 g, 73%) and contains ~15% impurity 
(1H NMR properties suggest a structure for this impurity involving the (6-phenyl-2-
pyridyl)methyl fragment). Attempts to purify the bppppa ligand further using various 
column conditions have thus proven unsuccessful. However use of this impure ligand did 
not cause problems in metal complexation reactions (see preparation of 1 below). The 
bppppa ligand can be isolated free of the impurity via treatment of crystalline 1 with 
NaCN in methanol/water to remove the Ni(II) ion (66% recovery yield).17 
Characterization data was recorded for clean bppppa obtained from the metal 
complexation/removal strategy: 1H NMR (CD3CN, 400 MHz) δ 8.15 (br, N-H), 8.05-8.02 
(m, 4H), 7.97 (d, J = 7.9 Hz, 1H), 7-78-7.74 (m, 2H), 7.71-7.76 (m, 3H), 7.71-7.67 (m, 
3H), 7.54 (d, J = 7.5 Hz, 2H), 7.48-7.38 (m, 7H), 3.97 (s, 4H), 3.87 (s, 2H), 1.24 (s, 9H); 
13C{1H} NMR (CD3CN, 100 MHz) δ 178.0, 160.5, 159.5, 157.0, 152.3, 140.4, 139.6, 
138.4, 129.9, 129.7, 127.8, 122.7, 119.6, 119.5, 112.7, 61.1, 60.9, 40.5, 27.6 (19 signals 
expected and observed); FTIR (neat, cm-1): 1690 (νc=o); LRFAB-MS (CH2Cl2:NBA) m/z 
(relative intensity); 542 ([M+H]+, 100%). Anal. Calcd. For C35H35N5O•1.75 H2O: C 
73.34; H, 6.77, N, 12.22. Found: C, 73.34; H, 6.39; N, 11.73. The presence of water in 
the sample was confirmed by 1H NMR. 
Caution! Perchlorate salts containing organic ligands are potentially explosive. 
These materials should be handled on a small scale and handled with great care.18 
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 [(bppppa)Ni(HONC(O)CH3)](ClO4)2 (1). To a methanol solution (~2 mL) of 
bpppa (41 mg, 0.075 mmol) was added a methanol solution (~2 mL) of Ni(ClO4)2•6H2O 
(27.6 mg, 0.075 mmol). The resulting mixture was stirred for 40 min at room temperature 
at which point a methanol solution (~1 mL) of acetohydroxamic acid (5.7 mg, 0.075 
mmol) was added. The pale blue solution was then stirred for overnight at room 
temperature. At this point, the solvent was removed under reduced pressure. 
Recrystallization of the residue via Et2O diffusion into a CH3OH:CH3CN (1:2.5) of the 
complex yielded purple crystals suitable for single crystal X-ray diffraction (48 mg, 
72%). UV-vis (CH3OH) [λmax, nm (ε, M-1cm-1)]:570 (15), 920 (20); FTIR (KBr, cm-1) 
1656 (νc=o, bppppa amide); µeff = 3.3 µB (298K); Anal. Calcd for C37H40N6O11Cl2Ni: C, 
50.91; H, 4.62; N, 9.63. Found: C, 50.51; H, 4.87; N, 9.49.  
 
Conclusions 
 In summary, we have found that a novel mononuclear Ni(II) complex having 
neutral acetohydroxamic acid coordination may be isolated using a chelate ligand that 
provides an internal hydrogen bond acceptor. The structural and spectrocopic properties 
of 1 are notably different from those of a structurally-related Ni(II) complex of the 
acetohydroxamato anion (2). This work provides the first chemical precedent upon which 
to evaluate acetohydroxamic acid versus acetohydroxamato anion coordination to a Ni(II) 
center, a topic that is important toward fully understanding the inhibition properties of 
urease enzymes.   
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CHAPTER 3 
CHEMISTRY OF A Ni(II) ACETOHYDROXAMIC ACID COMPLEX:  
FORMATION, REACTIVITY WITH WATER, AND ATTEMPTED  
PREPARATION OF ZINC AND COBALT ANALOGUES1 
 
Abstract 
Mononuclear Ni(II), Co(II), and Zn(II) complexes of the bppppa (N,N-bis[(6-
phenyl-2-pyridyl)methyl]-N-[(6-pivaloylamido-2-pyridyl)methyl]amine) ligand have 
been synthesized and characterized by X-ray crystallography, 1H NMR, UV-vis (Ni(II) 
and Co(II)), and infrared spectroscopy, and elemental analysis. Each complex has the 
empirical formula [(bppppa)M](ClO4)2 (M = Ni(II): 2; Zn(II): 3; Co(II): 4) and in the 
solid state exhibits a metal center having a coordination number of five, albeit the cation 
of 2 also has a sixth weak interaction involving a perchlorate anion. Treatment of 
[(bppppa)Ni](ClO4)2 (2) with one equivalent of acetohydroxamic acid results in the 
formation of [(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1) a novel Ni(II) complex having a 
coordinated neutral acetohydroxamic acid ligand. In 1, one phenyl-appended pyridyl 
donor of the bppppa chelate ligand is dissociated from the metal center and acts as a 
hydrogen bond acceptor for the hydroxyl group of the bound acetohydroxamic acid 
ligand.  Treatment of 1 with excess water results in the formation of 2 and free 
acetohydroxamic acid. We hypothesize that this reaction occurs due to disruption of the 
intramolecular hydrogen bonding interaction involving the bound acid. In this series of  
                                                          
1 Coauthored by Katarzyna Rudzka, Atta M. Arif, and Lisa M. Berreau. Reproduced with 
permission from Inorg. Chem. 2005, 44, 7234-7242. Copyright 2005 American Chemical 
Society.  
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reactions, the bppppa ligand exhibits behavior reminiscent of a Type III hemilabile ligand 
in terms of one phenyl-pyridyl donor. Treatment of 3 or 4 with acetohydroxamic acid 
results in no reaction, indicating that the bppppa-ligated Ni(II) derivative 2 exhibits 
unique coordination chemistry with respect to reaction with acetohydroxamic acid within 
this series of complexes. We attribute this reactivity to the ability of the bppppa-ligated 
Ni(II) center to adopt a pseudo-octahedral geometry, whereas the Zn(II) and Co(II) 
complexes retain five coordinate metal centers.  
 
Introduction 
 Recently we reported the synthesis and characterization of a novel mononuclear 
Ni(II) complex containing a neutral bidentate acetohydroxamic acid ligand, 
[(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1, Figure 3-1).1 A phenyl-appended pyridyl 
moiety of the supporting chelate ligand (bppppa, N,N-bis[(6-phenyl-2-pyridyl)methyl]-N-
[(6-pivaloylamido-2-pyridyl)methyl]amine) in 1 accepts a hydrogen bond from the 
hydroxyl group of the Ni(II)-coordinated acid. Complex 1 is interesting in that while 
structurally characterized examples of d-block metal complexes of the acetohydroxamate 
anion (AHA-) are common, particularly for Ni(II)2-5, Zn(II)5-7, and Co(II)5,8, complex 1 
represents the first example of a synthetic complex wherein neutral acetohydroxamic acid 
(AHA) ligation has been identified. 
 Notably, neutral acetohydroxamic acid coordination at a single Ni(II) center has 
been suggested for a weak enzyme/inhibitor complex (E-I) formed within the active site 
of urease enzymes obtained from Klebsiella aerogenes and Bacillus pasteurii (Figure 3-
2).9-11 Stabilization of this E-I species may involve a hydrogen-bonding interaction with 
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Figure 3-1. Drawing of [(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1). 
        
Figure 3-2. E-I species proposed to form in urease enzymes from Klebsiella aerogenes 
and Bacillus pasteurii. 
 
the bridging hydroxyl group.11 
 In the experiments reported herein, we have examined the formation of 1 from a 
Ni(II) precursor complex, [(bppppa)Ni](ClO4)2 (2). Paramagnetic 1H NMR and UV-vis 
measurements indicate that quantitative formation of 1 from 2 occurs in the presence of 
only a single equivalent of acetohydroxamic acid. However, the acid ligand of 1 can be 
displaced in the presence of water to regenerate 2 and free acetohydroxamic acid. 
Spectroscopic investigation of the reactivity of Zn(II) and Co(II) analogs of 2 with 
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acetohydroxamic acid revealed no evidence for formation of neutral acid-bound 
complexes of these metals. 
 
Experimental Section 
 General Methods. All reagents and solvents were obtained from commercial 
sources and used as received without further purification. The bppppa (N,N-bis[(6-
phenyl-2-pyridyl)methyl]-N-[(6-pivaloylamido-2-pyridyl)methyl]amine) ligand was 
prepared according to the literature procedure.1 
 Physical Methods. Diamagnetic 1H and 13C NMR spectra were collected using a 
Bruker ARX-400 spectrometer. Paramagnetic 1H NMR spectra were recorded as 
previously described.12 UV-vis spectra of 1, 2, and 4 were recorded at ambient 
temperature using a Hewlett Packard 8453 diode array spectrophotometer. Solid-state 
infrared spectra were recorded on a Shimadzu FTIR-8400 spectrometer as KBr pellets. 
Elemental analyses were performed by Atlantic Microlabs of Norcross, GA.  
Caution! Perchlorate salts of metal complexes with organic ligands are 
potentially explosive. Only small amounts of material should be prepared and these 
should be handled with great care.13 
General Method for Preparation of 2-4. Stirring of a methanol solution of the 
bppppa ligand (~ 0.06 mmol in ~4 mL methanol) with a molar equivalent amount of the 
appropriate metal perchlorate salt (M(ClO4)2•6H2O, M = Ni, Zn, Co), followed by 
removal of the solvent under reduced pressure, and recrystallization via Et2O diffusion 
into a CH3CN/CH3OH solution of the residue yielded the perchlorate complexes in >70% 
yield as single crystals suitable for X-ray crystallographic analysis. 
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[(bppppa)Ni](ClO4)2 (2). Yield: 72%. UV-vis, nm (ε, M-1cm-1) 572 (20), 890 
(26); FTIR (KBr, cm-1) 3354 (νN-H), 1620, 1099 (νClO4), 621 (νClO4). Anal. Calcd for 
C35H35N5O9Cl2Ni: C, 52.69; H, 4.43; N, 8.78. Found: C, 52.62; H, 4.22; N, 8.74.  
 [(bppppa)Zn](ClO4)2 (3). Yield: 82%. 1H NMR (CD3CN, 400 MHz): δ 8.82 (br 
s, 1H), 8.22-8.13 (m, 3H), 7.82-7.78 (m, 2H), 7.64-7.60 (m, 3H), 7.47-7.42 (m, 2H), 
7.37-7.33 (m, 4H), 7.25 (d, J = 7.4 Hz, 4H), 4.58-4.43 (m, 6H), 0.54 (s, 9H); 13C{1H} 
NMR (CD3CN, 100 MHz): δ 185.4, 160.5, 157.6, 153.5, 152.7, 144.8, 143.3, 139.2, 
131.5, 130.6, 129.0, 127.2, 124.6, 122.7, 117.7, 57.1, 56.7, 42.1, 26.7 (19 signals 
expected and observed); FTIR (KBr, cm-1) 3352 (νN-H), 1622, 1105 (νClO4), 621 (νClO4). 
Anal. Calcd for C35H35N5O9Cl2Zn: C, 52.16; H, 4.38; N, 8.69. Found: C, 52.29; H, 4.32; 
N, 8.68.  
 [(bppppa)Co](ClO4)2 (4). Yield: 76%. UV-vis, nm (ε, M-1cm-1) 470 (110), 590 
(50), 725 (30); FTIR (KBr, cm-1) 3433 (νN-H), 1618, 1105 (νClO4), 623 (νClO4). Anal. 
Calcd for C35H35N5O9Cl2Co: C, 52.62; H, 4.42; N, 8.77. Found: C, 52.63; H, 4.38; N, 
8.67.  
X-ray Crystallography. Crystals of 2-4 were each mounted on a glass fiber with 
viscous oil and then transferred to a Nonius KappaCCD diffractometer with Mo Kα 
radiation (λ = 0.71073 Å) for data collection at 150(1) K. The methodology used for 
determination of final unit cell constants has been previously reported.12 For the data 
collected for 2-4, each reflection was indexed, integrated, and corrected for Lorentz, 
polarization, and absorption effects using DENZO-SMN and SCALEPAC.14 All of the 
nonhydrogen atoms of 2-4 were refined with anisotropic displacement coefficients.  
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 Structure Solution and Refinement. Complexes 2-4 all crystallize in the space 
group P-1. For 2 and 4, all hydrogen atoms were located and refined independently using 
SHELXL97.15 For 3, all hydrogens except the amide proton were assigned isotropic 
displacement coefficients (U(H) = 1.2U(C) or 1.5U(Cmethyl)), and their coordinates 
were allowed to ride on their attached carbons using SHELXL97. The amide proton of 3 
was located and refined independently.  
 
Results  
 Synthesis. In order to more fully investigate coordination chemistry related to the 
formation and reactivity of the novel acetohydroxamic acid complex 
[(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1), a Ni(II) complex of the bppppa (N,N-bis[(6-
phenyl-2-pyridyl)methyl]-N-[(6-pivaloylamido-2-pyridyl)methyl]amine) chelate ligand, 
[(bppppa)Ni](ClO4)2 (2), was prepared as shown in Scheme 3-1. For complementary 
reactivity studies, Zn(II) ([(bppppa)Zn](ClO4)2, 3) and Co(II) ([(bppppa)Co](ClO4)2, 4)  
analogs were generated in a similar fashion. Complexes 2-4 were isolated as crystalline 
solids via recrystallization from CH3CN/CH3OH/Et2O solutions in yields that 
consistently exceeded 70%.  
 X-ray Crystallography. Part I. Parameters associated with the data collection 
and refinement of the X-ray structures of 2-4 are given in Table 3-1. Selected bond 
distances and angles are given in Table 3-2. 
 [(bppppa)Ni](ClO4)2 (2). An ORTEP representation of the cationic portion of 2, 
along with one ClO4- anion, is shown in Figure 3-3(a). The Ni(II) ion has a coordination 
geometry that may be described as intermediate between square pyramidal and trigonal 
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Scheme 3-1. Synthetic route for preparation of complexes 2-4.  
 
bipyramidal (τ = 0.54).16 Notably, the largest angular distortion from 120° within the 
pseudo equatorial plane is found in the N(2)-Ni(1)-N(5) bond angle (137.77(6)°).  This 
expanded angle is bisected by a weak interaction involving a perchlorate oxygen atom 
(Ni(1)…O(7) 2.975 Å). The Ni-O(amide) bond is ~0.08 Å shorter than the corresponding 
bond in 1.1 In addition, the average Ni-NPhPy distance in 2 (2.086 Å) is shorter than the 
Ni-NPhPy interaction in 1 (Ni(1)-N(4) 2.128(3) Å),1 and notably shorter than the Ni-NPhPy 
distances in [(6-Ph2TPA)Ni(ONHC(O)CH3)]ClO4 (2.2630(17) and 2.2292(17) Å, Figure 
3-4(a)) and [(6-Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)2•CH3OH (2.200(5) and 2.218(5) Å, 
Figure 3-4(b)).5 Following a similar trend, the bonding interactions involving the Ni(II) 
center of 2 and the tertiary amine nitrogen and amide-appended pyridyl donor are both 
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contracted relative to the same interactions in 1. In sum, these differences indicate an 
enhanced Lewis acidity for the five-coordinate Ni(II) center of 2 versus the six coordinate 
Ni(II) centers found in 1, [(6-Ph2TPA)Ni(ONHC(O)CH3)]ClO4 (Figure 3-4(a)) and [(6-
Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)2•CH3OH (Figure 3-4(b)).1,5  
 In the solid-state structure of 2, a t-butyl methyl group is positioned to form weak 
CH/π interactions with the phenyl appendages of the bppppa ligand (C(3)….arene 
centroid 3.95, 3.80 Å).17 While a similar interaction is not present in 1, where the shortest 
C(methyl)…arene centroid distance is 4.26 Å, CH/π interactions involving the methyl 
group of a Ni(II)-bound CH3CN ligand have been identified in [(6-
Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)2•CH3OH (C(methyl)…arene centroid, 3.66 and 
3.63 Å; Figure 3-4(b)). 
 Solution Characterization of [(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1) and 
[(bppppa)Ni](ClO4)2 (2). (a) Paramagnetic 1H NMR.  Recently we reported the 
solution characterization of a number of pseudo octahedral 6-Ph2TPA and TPA-ligated 
Ni(II) complexes using paramagnetic 1H NMR.12  In that work, we used as variety of 
deuterated ligand derivatives, as well as 2H NMR and two-dimensional 1H-1H COSY 
spectra, to assign the 1H NMR resonances of the supporting chelate ligands. As shown in 
Figure 3-5(a), we were able to clearly assign the β-H resonances (protons on meta 
positions) of the pyridyl rings in [(6-Ph2TPA)Ni(CH3CN)CH3OH)](ClO4)2 in the region 
of ~39-60 ppm. The β and β’ designations differentiate the pyridyl (β) and phenylpyridyl 
(β’) donors in 1. Notably, a similar, albeit more complex set of resonances is observed for 
1 under identical conditions (Figure 3-5(b)). We assign the resonances at 63.7, 53.9, 38.7, 
and 34.9 ppm in 2 as β or β’-H’s on the basis of similarity in chemical shift to the β/β’- 
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Figure 3-3. ORTEP representations of the cationic portions of 2-4. For all, ellipsoids are 
ploted at the 50% probability level and hydrogen atoms, except the amide N-H proton, 
have been omitted for clarity. 
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Figure 3-4. Drawings of 6-Ph2TPA, (a) [(6-Ph2TPA)Ni(ONHC(O)CH3)]ClO4, and (b) 
[(6-Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)2•CH3OH.  
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Table 3-1. Summary of X-ray Data Collection and Refinement 
 2 3 4
empirical formula C35H35Cl2N5O9Ni C35H35Cl2N5O9Zn C35H35Cl2N5O9Co 
formula weight 799.29 805.95 799.51 
crystal system triclinic triclinic triclinic 
space group P-1 P-1 P-1 
a (Å) 11.1285(3) 11.1799(3) 11.1919(2) 
b (Å) 11.7383(4) 11.8178(2) 11.7809(2) 
c (Å) 14.7611(2) 14.6539(4) 14.6419(3) 
α (deg) 87.7231(16) 86.8463(15) 86.6445(13) 
β (deg) 70.8954(14) 70.8582(12) 70.8059(11) 
γ (deg) 67.5294(12) 67.8369(13) 67.9376(11) 
V (Å3) 1675.63(8) 1688.68(7) 1685.06(5) 
Z 2 2 2 
density (calcd), Mg m-3 1.584 1.585 1.576 
temp (K) 150(1) 150(1) 150(1) 
color purple colorless green 
crystal habit plate plate plate 
crystal size (mm) 0.40 x 0.38 x 0.15 0.30 x 0.20 x 0.05 0.35 x 0.28 x 0.08 
diffractometer Nonius KappaCCD Nonius KappaCCD Nonius KappaCCD 
abs. coeff. (mm-1) 0.805 0.951 0.734 
2θ max (deg) 54.92 54.96 54.96 
Completeness to 2θ  (%) 99.2 98.5 99.3 
reflections collected 11376 11176 12467 
indep. reflections 7601 7627  7677  
 [R(int)=0.0179] [R(int) = 0.0264] [R(int)= 0.0254] 
variable parameters 610 476 610 
R1 / wR2b 0.0332/0.0740 0.0417/0.0852 0.0384/0.0786 
goodness-of-fit (F2) 1.043 1.071 1.070 
largest diff. (e Å-3) 0.340/-0.473 0.379/-0.530 0.478/-0.382 
aRadiation used: Mo Kα (λ = 0.71073 Å).  
bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|;  
wR2 = [∑[w(Fo2-Fc2)2]/[∑(Fo2)2]]1/2  
where w = 1/[σ2(Fo2) + (aP)2 + bP]. 
 
Table 3-2. Selected Bond Distances (Å) and Angles (˚) 
 2 3 4
M-N(2) 1.9945(15) 2.0667(19) 2.0441(17)
M-N(3) 2.0427(14) 2.1500(2) 2.1431(17)
M-N(4) 2.0676(15) 2.0758(19) 2.0819(16)
M-N(5) 2.1051(15) 2.1030(2) 2.0971(16)
M-O(1) 1.9563(12) 1.9696(16) 1.9640(14)
N(2)-M-N(4) 106.93(6) 110.69(8) 110.14(6)
N(4)-M-N(5) 108.51(6) 112.89(8) 112.49(7)
N(2)-M-N(5) 137.77(6) 126.03(7) 125.12(7)
O(1)-M-N(2) 90.41(5) 88.64(7) 89.54(6)
O(1)-M-N(4) 107.91(5) 114.86(7) 115.30(6)
O(1)-M-N(5) 99.78(5) 100.31(7) 101.68(6)
O(1)-M-N(3) 170.39(6) 164.04(7) 165.22(6)
N(2)-M-N(3) 84.03(6) 80.03(8) 79.66(7)
N(4)-M-N(3) 81.28(6) 79.93(8) 78.21(6)
N(5)-M-N(3) 79.41(6) 77.86(8) 76.94(6)
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H’s of [(6-Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)2·CH3OH, as well as other Ni(II) 
derivatives of the 6-Ph2TPA and TPA ligands.12 However, unlike the β and β’-H 
resonances of [(6-Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)2·CH3OH, which appear in a 
1:2:1:2 relative intensity ratio, the four sharpest signals assigned as β/β’-H resonances for 
1 appear with a 1:1:1:1 integrated relative intensity. This can be explained by the fact that 
all three pyridyl rings are inequivalent for 1 and that these four sharp signals represent the 
β/β’-H protons of only two of the pyridyl rings. The β-H resonances of the third pyridyl 
ring remain to be identified. However, we hypothesize that this missing set of β-H 
resonances for 1 is for the noncoordinated phenylpyridyl donor that is involved in the 
hydrogen-bonding interaction with the bound acetohydroxamic acid. Because these 
protons are positioned further from the nickel center than the other pyridyl β/β’-H’s, their 
1H NMR signals are likely in or near the diamagnetic region, which is obscured by 
additional ligand and solvent resonances. For 2, which has a five-coordinate Ni(II) center 
in the solid state (with a weak sixth perchlorate oxygen interaction), the paramagnetic 1H 
NMR features of the complex in dry CD3CN are strikingly different from those of 1 and 
other pseudo octahedral Ni(II) complexes that we have investigated.12 First, there are 
only two cleanly identifiable β-type resonances at 68.0 and 46.3 ppm, respectively. These 
signals exhibit a 1:1 integrated intensity ratio. Several additional broad features are 
present in the range of ~0-40 ppm, which have not been assigned. Notably, both 1 and 2 
exhibit a resonance upfield of 0 ppm (Figure 3-5(b) and(c)). Based on the fact that these 
signals disappear in the presence of D2O, they are assigned as the amide N-H protons in 
these complexes. Addition of a large excess of D2O (~600 eq) to a CD3CN solution of the 
acetohydroxamic acid complex 1 also produces additional changes consistent with the 
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release of the acid ligand (vide infra). Importantly, these preliminary paramagnetic 1H 
NMR studies indicate that 1 and 2 exhibit unique paramagnetic 1H NMR signatures that 
may be used, in conjunction with complementary electronic absorption spectroscopic 
 
  
Figure 3-5. Paramagnetic 1H NMR spectra of (a) [(6-
Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)212, (b) 1, and (c) 2. All spectra were collected in 
dry CD3CN solution at 25(1) °C. 
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Figure 3-6. Electronic absorption spectroscopic features of 1 and 2. 
 
experiments (vide infra), to monitor the solution reactivity 2 with acetohydroxamic acid, 
a reaction that results in the formation of 1.  
(b) Electronic Absorption Spectroscopy. The electronic absorption 
spectroscopic properties of 2 are subtly different from those of 1, as shown in Figure 3-6, 
thus giving a secondary technique with which to monitor reactions involving these 
complexes. In particular, the 3A2g → 3T2g(F) transition at ~890 nm in 2, is shifted into the 
near-IR region in 1.18 
Reactivity of 2 with Acetohydroxamic Acid Results in the Formation of 1. 
Evaluation by Paramagnetic 1H NMR and Electronic Absorption Spectroscopy. 
Treatment of [(bppppa)Ni](ClO4)2, 2, with one equivalent of acetohydroxamic acid in 
CD3CN solution results in spectral changes in the paramagnetic 1H NMR consistent with 
the formation of the acetohydroxamic acid complex, 1 (Scheme 3-2). As shown in Figure 
3-7, the formation of [(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1, Figure 3-7(b)) is 
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indicated by the appearance of four β-H resonances of equal intensity in the region of 30-
70 ppm. The chemical shifts of these resonances exactly match those observed for 
analytically pure 1 under identical conditions (Figure 3-7(d)). Formation of 1 appears to 
be complete upon the addition of one equivalent of acetohydroxamic acid to 2 (Scheme 
2), as the addition of a second equivalent of acetohydroxamic acid results in no additional 
changes in the observed 1H NMR features (Figure 3-7(c)).  As shown in Figure 3-8, 
electronic absorption spectroscopic changes produced upon treatment of 2 with one 
equivalent of acetohydroxamic acid also indicate the clean formation of 1. 
 
 Displacement of Acetohydroxamic Acid from 1 Occurs in the Presence of 
Water to Yield 2. Treatment of 1 with excess equivalents of water results in 1H NMR 
spectroscopic changes (Figure 3-9(a)-(d)) that indicate the displacement of the 
acetohydroxamic acid ligand from 1 and the formation of 2. As shown in Figure 3-9(b), 
 
 
Scheme 3-2. Formation of [(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1) in dry CH3CN and 
displacement of acetohydroxamic acid upon addition of H2O.  
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Figure 3-7. β-H region of the paramagnetic 1H NMR spectra of (a) 2, (b) 2 in the 
presence of one equivalent of acetohydroxamic acid, (c) 2 in the presence of two 
equivalents of acetohydroxamic acid, and (d) analytically pure 1. All spectra were 
recorded at 25(1) °C in CD3CN. 
 
addition of 100 eq. of D2O to a CD3CN solution of 1 yields subtle spectral changes in the 
β-H region as compared to those observed for analytically pure 
[(bppppa)Ni(HONHC(O)CH3)](ClO4)2 (1) under identical conditions (Figure 3-9(a)). 
Addition of increasing equivalents of water, up to 600 equivalents total (Figures 3-9(c) 
and 3-9(d)) results in the generation of a paramagnetic 1H NMR spectrum identical to that 
exhibited by analytically pure 2 under identical conditions. (Figure 3-9(e)) Examination 
of the diamagnetic region of these same spectra (Figure 3-10) supports a similar 
interpretation. This conclusion is further supported by the fact that precipitation of 
analytically pure 1 from a CH3CN/acetone/water (~20%/~10%/70%) solution, followed 
by recrystallization of the precipitated solid from CH3CN/Et2O, yields crystalline 2. The 
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identification of this crystalline solid as 2 was confirmed by X-ray crystallographic 
determination of the unit cell parameters, which matched those previously determined for 
2. As shown in Scheme 3-2, these results indicate hemilabile behavior for the supporting 
bppppa ligand when coordinated to Ni(II).19,20 In the presence of acetohydroxamic acid, 
the five-coordinate Ni(II) complex 2 undergoes dissociation of one of the phenyl-
appended pyridyl donors resulting in stabilization of the acetohydroxamic acid complex 1 
via an intramolecular hydrogen-bonding interaction. However, in the presence of excess 
water, the acetohydroxamic acid ligand is displaced and complex 2 is regenerated. 
 
 
Figure 3-8. Electronic absorption spectroscopic changes produced upon treatment of 2 
with one equivalent of acetohydroxamic acid.  These changes produce an absorption 
spectrum (dashed line) that is indistinguishable from that observed for analytically pure 1 
in CH3CN solution (dashed line with diamond-shaped markers).  
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Will Acetohydroxamic Acid Complexes Form with Other d-Block Metals? 
Evaluation of the Reactivity of Zn(II) and Co(II) Analogs of 2 with 
Acetohydroxamic Acid. To our knowledge, 2 is the first d-block metal complex to be 
reported that reacts with acetohydroxamic acid to produce an isolable metal complex 
having a neutral, coordinated acetohydroxamic acid ligand.1 To test whether this 
reactivity will be common in other d-block metal complexes of the bppppa chelate ligand, 
we have generated Zn(II) ([(bppppa)Zn](ClO4)2, 3)  and Co(II) ([(bppppa)Co](ClO4)2, 4), 
analogs of 2. These metals were chosen due to the propensity of acetohydroxamate 
complexes known of these d-block metals.5-8 
 
 
Figure 3-9.   Spectrum (a) shows the β-H region of the paramagnetic 1H NMR spectrum 
of 1 in CD3CN at 25(1) °C. Spectra (b)-(d) show this solution plus (b) 100 eq, (c) 350 eq, 
and (d) 600 eq D2O.  Spectrum (e) is for analytically pure 2 in CD3CN containing 600 eq 
D2O. 
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X-ray Crystallography. Part II. The cationic portions of 3 and 4 are shown in 
Figure 3-3(b) and (c). As with the Ni(II) derivative 2, the metal centers of 3 and 4 both 
exhibit an overall coordination number of five. Within each cation, there are weak CH/π 
interactions akin to those found for 2.17 The geometry of the cations of 3 and 4 is best 
described as distorted trigonal bipyramidal (3: τ = 0.63; 4: τ = 0.67).16 As previously 
noted, the Ni(II) center of 2 is intermediate between square pyramidal and trigonal 
bipyramidal (τ = 0.54). Key structural differences for the zinc and cobalt cations, versus 
the nickel analog 2 are: (a) a subtle decrease in the linearity of the O(1)-M-N(3) 
interaction, (b) a more acute equatorial NAmPy-M-NPhPy angle (e.g. 2: N(2)-Ni-N(5) 
137.77°; 3: N(2)-Zn-N(5) 126.03°),  and (c) more open N(2)-M-N(4) (~110°) and N(4)-
M-N(5) (~112°) bond angles in the equatorial plane for the cations of 3 and 4. In 
addition, for the Zn(II) and Co(II) complexes, no interaction is found between the cation 
and either of the perchlorate anions. Thus, the nickel derivative 2 is unique within this 
subset of complexes in having a weak sixth interaction involving a perchlorate anion. 
This interaction, which bisects the N(2)-Ni-N(5) angle, provides a rationale for the 
differences in the equatorial bond angles of 3 and 4, versus those of 2, as described 
above.  
 Solution Characterization of [(bppppa)Zn](ClO4)2 (3) and 
[(bppppa)Co](ClO4)2 (4) in the Absence and Presence of Acetohydroxamic Acid.  
The 1H NMR features of 3 in CD3CN solution at 25(1) °C are given in the experimental 
section. The most notable 1H NMR feature of this complex is an upfield shift of the t-
butyl methyl protons of the supporting bppppa chelate ligand (3: 0.56 ppm) relative to 
chemical shift position of this signal for the free ligand (1.24 ppm). This shielding effect 
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may be attributed to the weak CH/π interaction between the t-butyl methyl protons and 
the phenyl appendages of the bppppa ligand, as noted in the solid-state structure of 3.17 
Addition of excess acetohydroxamic acid (10 eq) to a CD3CN solution of 3 results 
in the appearance of new signals at ~9.1, 7.6, and 1.8 ppm. These resonances are at 
chemical shifts consistent with the presence of free acetohydroxamic acid in CD3CN 
solution. No changes were found in terms of the multiplicity or chemical shifts of the 
resonances of 3 in the presence of the acid. This indicates that no reaction takes 
place between the zinc complex and acetohydroxamic acid. 
The Co(II) complex 4 exhibits three electronic transitions (470 (110), ~590 (50), 
725 (30) nm; Figure 3-11), with extinction coefficients consistent with a five-coordinate 
Co(II) center for 4 in CH3CN solution.18 Measurement of the absorption spectrum of 4 in 
the presence of ten equivalents of acetohydroxamic acid in CH3CN produced no change 
in the intensity or wavelength of the electronic transitions, suggesting that no reaction 
occurs.  
Paramagnetic 1H NMR can also be used to probe the solution reactivity of Co(II) 
compounds.21 Shown in the (a) portions of Figure 3-12 are the features found in two 
different regions of the paramagnetic 1H NMR spectrum of 4. Assignment of selected 
resonances has been performed on the basis of integrated intensity and comparison of 
spectral features to assigned resonances of structurally-related mononuclear Co(II) 
complexes.21 Two sharp signals at 74.9 and 35.2 ppm, respectively, are assigned as the β-
H’s of the phenyl-appended pyridyl rings.  A 1H-1H COSY spectrum of 4 (data not 
shown) indicates that these signals are coupled to a γ-H (para to the pyridyl nitrogen) 
resonance at 0.26 ppm. The t-butyl methyl resonance is present at 13.8 ppm. The signal at 
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Figure 3-10. Spectrum (a) shows the diamagnetic region of the paramagnetic 1H NMR 
spectrum of 1 in CD3CN at 25(1) °C. Spectra (b)-(d) show this solution plus (b) 100 eq, 
(c) 350 eq, and (d) 600 eq D2O.  Spectrum (e) is for analytically pure 2 in CD3CN 
containing 600 eq D2O. 
 
-15.6 ppm disappears in the presence of D2O and is assigned as the amide N-H resonance 
for 4. In the (b) and (c) portions of Figure 3-12 are the NMR spectra produced upon 
treatment of 4 with 10 and 20 equivalents of acetohydroxamic acid, respectively. Similar 
to the electronic absorption spectroscopic results, the NMR data indicates that no reaction 
occurs between 4 and the acid.  
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Discussion  
 We recently reported the isolation and structural characterization of 
[(bppppa)Ni(HONHC(O)CH3)](ClO4)2, 1.1 This complex has biological relevance, as 
neutral acetohydroxamic acid coordination has been suggested for a weak 
enzyme/inhibitor (E-I) complex involving  the active site nickel cluster of urease.9-11 
From a coordination chemistry perspective, 1 is unique in being the first reported 
example of a d-block metal complex having a coordinated neutral acetohydroxamic acid 
ligand.22 In the work described herein, we have performed experiments to probe the 
formation and reactivity of 1 in acetonitrile solution. Formation of 1 from a five-
coordinate Ni(II) precursor complex, [(bppppa)Ni](ClO4)2 (2), and one equivalent of 
acetohydroxamic acid occurs readily at ambient temperature.  The paramagnetic 1H NMR 
and electronic absorption spectroscopic features of 1 and 2 differ sufficiently so that 
Ni(II) coordination of the acetohydroxamic ligand is easily identifiable. 
 
  
 
Figure 3-11. The solid line is the electronic absorption spectrum of 4 in CH3CN at 25(1) 
°C.  The dashed line is the absorption spectrum of 4 in the presence of ten equivalents of 
acetohydroxamic acid. 
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 Potentially tetradentate tris((pyridyl)methyl)amine-type ligands  with an aryl or 
alkyl appendage in the α position of a pyridyl ring, have been previously shown to 
exhibit tridentate coordination modes in Fe(II) and Fe(III) complexes, with an α- 
functionalized pyridyl donor dissociated from the metal center.23-25 In 1, a noncoordinated 
phenyl-appended pyridyl donor acts as a hydrogen bond acceptor for the 
coordinated acetohydroxamic acid ligand.1 The structural parameters of this hydrogen-
bonding interaction indicate that it may be classified as moderate and involves an energy 
of 4-14 kcal/mol.1,26 A similar hydrogen-bonding interaction was identified in a Mn(II) 
  
Figure 3-12. Spectra labeled (a) show features of the paramagnetic 1H NMR spectrum of 
4 in CD3CN at 25(1) ° C. Spectra labeled as (b) and (c) show (a) with 10 and 20 eq of 
acetohydroxamic acid added, respectively.  The resonances labeled with (*) indicate the 
presence of free acetohydroxamic acid. The solvent residual proton resonance is found at 
1.94 ppm. 
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complex of the 6-Ph2TPA ligand, wherein a noncoordinated phenyl-appended pyridyl 
nitrogen atom acts as a hydrogen bond acceptor for a metal-coordinated methanol ligand.5 
Treatment of 1 with excess water results in the release of acetohydroxamic acid and 
formation of 2, a complex that does not have a coordinated water ligand. Our hypothesis 
is that the presence of water disrupts the intramolecular hydrogen bonding interaction 
involving the coordinated acetohydroxamic acid ligand. This disruption could produce a 
structure in which coordination of the hydroxamic acid is thermodynamically disfavored 
with respect to release of the neutral acid and formation of 2.  
The binding of the acid to 2 to form 1 involves behavior of the bppppa ligand that 
is reminiscent of a Type III hemilabile ligand, as defined by Braunstein and Naud.20 
Specifically, type III hemilabile behavior (Figure 3-13(top)) involves coordination of an 
external reagent that results in the breaking of a labile metal-ligand bond.20 Typical Type 
III hemilabile systems involve CO, or another gaseous reactant (e.g. CO2, SO2) as the 
external reagent, and the reversibility of the reaction results simply from a change in the 
partial pressure of the gas. In the reaction to produce 1 from 2, the dissociated ligand 
appendage is a phenyl-appended pyridyl moiety that accepts a hydrogen bond from the 
bound acid (Figure 3-13(bottom)). The introduction of water results in release of the acid. 
As discussed above, we hypothesize that this involves water acting to disrupt the 
intramolecular hydrogen bonding interaction. These results indicate that coordination of a 
neutral acetohdyroxamic acid ligand to a Ni(II) center, even when stabilized via an 
intramolecular hydrogen bonding interaction, is susceptible to displacement in the 
presence of water.  Thus, a neutral acetohydroxamic acid adduct in a biological system, 
such as is proposed to occur in the weak enzyme/inhibitor E-I complex of urease, could 
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be disrupted in the presence of water.  
As outlined above, Zn(II) and Co(II) analogs of 2 do not form complexes having a 
neutral acetohydroxamic acid ligand, even in the presence of a large excess of the acid. 
We rationalize this lack of reactivity in terms of coordination number preferences for the 
bppppa-ligated metal centers. Specifically, whereas the Ni(II) complex 2 forms a sixth 
weak interaction with a perchlorate anion in the solid state, and exhibits a geometry 
approximately half-way between square pyramidal and trigonal bipyramidal, the Zn(II) 
and Co(II) complexes (3 and 4) have strictly five-coordinate distorted trigonal 
bipyramidal metal centers. Based on this data, it appears that the key to forming the 
acetohydroxamic acid complex, 1, is the ability of the nickel center to form a sixth 
interaction and adopt a pseudo-octahedral geometry. 
 
   
Figure 3-13. (top) Type III hemilabile ligand behavior as defined by Braunstein and 
Naud.20 (bottom) Reactivity properties of 2 and 1. 
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CHAPTER 4 
GLYOXALASE I-TYPE HEMITHIOACETAL ISOMERIZATION REACTIVITY OF 
A MONONUCLEAR Ni(II) DEPROTONATED AMIDE COMPLEX1 
 
Abstract 
The synthesis, characterization, and hemithioacetal isomerization reactivity of a 
mononuclear Ni(II) deprotonated amide complex, [(bppppa–)Ni]ClO4·CH3OH (1, bppppa- 
= monoanion of N,N-bis-[(6-phenyl-2-pyridyl)methyl]-N-[(6-pivaloylamido-2-
pyridyl)methyl]amine) is reported. Complex 1 was characterized by X-ray 
crystallography, 1H NMR, UV-vis, FTIR, and elemental analysis. Treatment of 1 with an 
equimolar amount of the hemithioacetal PhC(O)CH(OH)SCD3 in dry acetonitrile results 
in the production of the thioester PhCH(OH)C(O)SCD3 in ~60% yield. This reaction is 
conveniently monitored by 2H NMR. A protonated analog of 1, [(bppppa)Ni](ClO4)2 (2), 
is unreactive with the hemithioacetal, thus indicating the requirement of the anionic 
chelate ligand in 1 for hemithioacetal isomerization reactivity. Complex 1 is unreactive 
with the thioester product, PhCH(OH)C(O)SCD3, which indicates that the pKa value for 
the PhCH(OH)C(O)SCD3 proton of the thioester must be significantly higher than the 
pKa value of the C-H proton of the hemithioacetal (PhC(O)CH(OH)SCD3). Complex 1 is 
the first well-characterized Ni(II) coordination complex to exhibit reactivity relevant to 
Ni(II)-containing E. coli glyoxalase I. Treatment of NiBr2⋅2H2O with 
PhC(O)CH(OH)SCD3 in the presence of 1-methylpyrrolidine also yields thioester 
                                                   
1 Coauthored by Katarzyna Rudzka, Atta M. Arif, and Lisa M. Berreau. Reproduced with 
permission from J. Am. Chem. Soc. 2006, 128, 17018-17023. Copyright 2006 American 
Chemical Society.  
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product, albeit the reaction is slower and involves the formation of multiple –SCD3 
labeled species, as detected by 2H NMR. The results of this study provide the first insight 
into hemithioacetal isomerization promoted by a synthetic Ni(II) coordination complex 
versus a simple Ni(II) ion. 
 
Introduction 
The glyoxalase system catalyzes the detoxification of cytotoxic 2-oxoaldehydes 
(e.g. methyl glyoxal, CH3C(O)C(O)H) by a two step reaction pathway.1 In the first step, 
glyoxalase I (GlxI) catalyzes the isomerization of a hemithioacetal to produce a thioester 
(Scheme 4-1). Glyoxalase II (GlxII) then catalyzes the hydrolysis of the thioester to 
produce free glutathione and a 2-hydroxy acid. The GlxI enzyme from Escherichia coli 
contains a mononuclear Ni(II) center within the enzyme active site.2,3 Bacterial GlxI 
enzymes from Y. pestis, P. aeruginosa, and N. meningitidis also exhibit maximal activity 
in the presence of Ni(II).4 Recently, the GlxI from the human parasite Leishmania major 
was also found to be a Ni(II)-dependent enzyme.5 An X-ray crystal structure of the E. 
coli GlxI enzyme revealed a distorted octahedral Ni(II) center having a mixture of 
nitrogen and oxygen donor ligands, [(NHis)2(OGlu)2Ni(OH2)2] (Scheme 4-1).6  
 
 
Scheme 4-1. The reaction pathway for the glyoxalase system. 
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Scheme 4-2. The proposed mechanism for E. coli glyoxalase I reaction. 
 
The role of the Ni(II) center in the E. coli GlxI-mediated hemithioacetal 
isomerization reaction is not yet defined.7,8 On the basis of X-ray absorption 
spectroscopic studies of product- and inhibitor-bound E. coli GlxI, a mechanistic pathway 
is favored in which the role of Ni(II) ion is to generate a nickel hydroxide moiety that can 
serve as a general base for the isomerization reaction.7,8 Specifically, the Ni(II)-OH is 
proposed to abstract a proton from the hemithioacetal (Scheme 4-2). In this reaction, an 
anion is produced that is subsequently protonated at the former carbonyl carbon to yield 
the thioester product.9 It is unclear whether the intermediate anion in this reaction 
transiently interacts with the Ni(II) center. X-ray absorption studies of the enzyme-
product complex of E. coli GlxI show no evidence of Ni(II)-product interactions, leading  
previous researchers to favor the proton transfer mechanism shown in Scheme 4-2.  
To date, only three structurally characterized mononuclear Ni(II)-OH complexes 
have been reported in the literature.10 Neither these complexes or any other mononuclear 
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Ni(II) complex has been shown to promote the isomerization of a hemithioacetal in a 
fashion akin to that proposed for E. coli GlxI. In 1970, a single brief report appeared in 
the literature in which the use of NiBr2·2H2O and the base 1-methylpyrrolidine was 
indicated to promote the isomerization of a hemithioacetal to produce a thioester produt 
in DMF.11 No experimental details or yield of the thioester product were reported for this 
reaction.  
In the work described herein, we have explored the hemithioacetal isomerization 
reactivity of mononuclear Ni(II) complex supported by a chelate ligand containing an 
oxygen-coordinated deprotonated amide ligand. This complex, which was produced 
during attempts to generate a mononuclear Ni(II)-OH complex, promotes the 
isomerization of a hemithioacetal to produce a thioester product. Importantly, this is the 
first synthetic Ni(II) complex to be reported that exhibits glyoxalase I type reactivity. 
Control studies indicate that the presence of the deprotonated amide in the supporting 
chelate ligand is required for hemithioacetal isomerization reactivity. Additionally, we 
have reexamined the previously reported hemithioacetal isomerization reaction promoted 
by NiBr2·2H2O/1-methylpyrrolidine in DMF.11 Using a deuterium labeled hemithioacetal 
and 2H NMR, we have found that while thioester formation does occur, this reaction is 
significantly slower than the reaction involving the deprotonated amide complex. These 
hemithioacetal isomerization reactions also differ in the nature of intermediate species 
that are detectable by 2H NMR. For the reaction involving the deprotonated amide 
coordination complex, no evidence was found for Ni(II)-coordinated intermediates 
whereas in the NiBr2·2H2O-promoted reaction several spectroscopically identifiable new 
species are present in the reaction mixture, some of which may involve coordination 
78 
between the hemithioacetal and Ni(II). Overall, the results of this study provide the first 
insight into hemithioacetal isomerization promoted by a well-characterized synthetic 
Ni(II) complex versus simple Ni(II) ion.  
 
Results and Discussion 
Synthesis and Characterization of [(bppppa-)Ni]ClO4 (1). Chelate ligands 
containing secondary amide appendages have been shown to stabilize a variety of 
mononuclear metal hydroxide complexes.12-16 With this in mind, we attempted to prepare 
a new mononuclear Ni(II)-OH complex starting from the X-ray crystallographically 
characterized mononuclear Ni(II) complex [(bppppa)Ni](ClO4)2 (2, Scheme 4-3).17 
Treatment of this complex with one equivalent of Me4NOH⋅5H2O in CH3CN resulted in 
the formation of an orange/brown solution. Following work-up and recrystallization from 
CH3CN/CH3OH/Et2O, [(bppppa–)Ni]ClO4·CH3OH (1) was isolated in 68% yield as 
orange-brown crystals. Complex 1 has been characterized by X-ray crystallography, 1H 
NMR, UV-vis, FTIR, and elemental analysis. These combined characterization methods 
indicate that instead of formation of the desired mononuclear Ni(II)-OH complex, 
treatment of 2 with one equivalent of base resulted in the formation of a deprotonated 
amide complex.  
 
 
Scheme 4-3. The synthesis of a Ni(II) deprotonated amide complex.  
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Figure 4-1. Top: ORTEP drawing of the cationic portion of 1. Ellipsoids are drawn at the 
50% probability level. Hydrogen atoms are omitted for clarity. Bottom: Comparison of 
bond distances within the cationic portions of 1 and 2. 
 
An ORTEP drawing of the cationic portion of 1 is shown in Figure 4-1. Details of 
the X-ray data collection and refinement are given in Table 4-1. Selected bond distances 
in 1 and its parent complex [(bppppa)Ni](ClO4)217 (2) are provided in Figure 4-1. 
Additional bond distances and angles for 1 are given in Table 4-2. As expected, the 
presence of the deprotonated amide in 1 results in a slight contraction of the C(5)-N(1) 
bond and elongation of the amide C(5)-O(1) bond (Figure 4-1 (bottom)) relative to the 
distances found in the structurally similar 2 wherein a protonated amide is present. The  
shorter C(6)-N(1) distance in 1 (1.373(4) Å) may be attributed to delocalization of the 
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Table 4-1. Summary of X-ray Data Collection and Refinement 
 1
empirical formula C36H38ClN5NiO6
formula weight 730.87 
crystal system orthorhombic 
space group Pb21a 
a (Å) 13.0931(3) 
b (Å) 13.8192(2) 
c (Å) 18.4276(4) 
α (deg) 90 
β (deg) 90 
γ (deg) 90 
V (Å3) 3334.22(12) 
Z 4 
density (calcd), Mg m-3 1.456 
temp (K) 150(1) 
color brown 
crystal habit plate 
crystal size (mm) 0.33 x 0.20 x 0.08 
diffractometer Nonius KappaCCD 
abs. coeff. (mm-1) 0.717 
2θ max (deg) 54.96 
completeness to θ  = 27.48° 99.8% 
reflections collected 7306  
indep. reflections 7306 [R(int) = 0.0000]
variable parameters 476 
R1 / wR2b 0.0437/0.0926 
goodness-of-fit (F2) 1.102 
largest diff. (e Å-3) 0.460/-0.581 
aRadiation used: Mo Kα (λ = 0.71073 Å).  
bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|;  
wR2 = [∑[w(Fo2-Fc2)2]/[∑(Fo2)2]]1/2  
where w = 1/[σ2(Fo2) + (aP)2 + bP]. 
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Table 4-2. Selected Bond Distances (Å) and Angles (o)a 
 1
Ni-O(1) 1.916(2) 
Ni-N(2) 1.989(3) 
Ni-N(3) 2.056(3) 
Ni-N(4) 2.148(3) 
Ni-N(5) 2.076(3) 
O(1)-Ni-N(2) 89.94(10) 
O(1)-Ni-N(3) 163.44(11) 
N(2)-Ni-N(3) 83.72(11) 
O(1)-Ni-N(5) 115.51(10) 
N(2)-Ni-N(5) 110.17(11) 
N(3)-Ni-N(5) 81.05(9) 
O(1)-Ni-N(4) 95.63(10) 
N(2)-Ni-N(4) 136.87(10) 
N(3)-Ni-N(4) 78.97(10) 
N(5)-Ni-N(4) 105.72(10) 
aEstimated standard deviations indicated in parentheses. 
 
anionic charge into the pyridyl ring.1H NMR spectroscopic evidence for such 
delocalization has been previously reported for a zinc analog complex.18 This 
delocalization, along with the presence of the Ni(II) ion, stabilizes the deprotonated 
amide moiety in 1. Notably, the average Ni(1)-NPhPy distance increases slightly in 1 (2.11 
Å) relative to that found in 2 (2.09 Å). This is an indication of a less Lewis acidic Ni(II) 
center in 1. The Ni(II) center in both complexes exhibits a geometry that is intermediate 
between trigonal bipyramidal and square pyramidal (1: τ = 0.44; 2: τ = 0.54).19  
A region of the 1H NMR spectra of 1 and 2 is shown in Figure 4-2. Three sharp 
resonances are present in the spectrum of 1 in the range of 30-50 ppm that clearly 
differentiate the spectrum of this complex from that of its protonated parent complex. 
Based on studies of a series of mononuclear Ni(II) complexes of the 6-Ph2TPA ligand, 
these resonances are assigned to the β/β’-H’s of the pyridyl rings.20 Complex 1 is orange  
when dissolved in acetonitrile, with an absorption feature at 440 nm (ε = 320 M-1cm-1). 
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Figure 4- 2. A region of the 1H NMR spectra of 1 (a) and 2 (b). Both spectra were 
acquired in CD3CN solution at 302 K. 
 
This feature is not present in the UV-vis spectrum of 2. 
Hemithioacetal Isomerization Reactivity of 1. Our initial goal was to generate a 
new mononuclear Ni(II)-OH complex and examine its reactivity with a hemithioacetal. 
Although 1 does not contain a Ni(II)-OH moiety, it does contain a Ni(II)-bound anionic 
ligand in the form of a deprotonated amide. While this functional group is not directly 
relevant to the chemistry proposed for E. coli Glx I, we decided to initially continue our 
studies with this complex as to date no synthetic Ni(II) coordination complex has been 
shown to promote the isomerization of a hemithioacetal. Treatment of 1 with a 
stoichiometric amount of the hemithioacetal PhC(O)CH(OH)SCD321 in dry CH3CN at  
302 K results in hemithioacetal isomerization over the course of ~1.5 h to produce 
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Scheme 4-4. Hemithioacetal isomerization reaction (top); control reaction (bottom).  
 
the thioester PhCH(OH)C(O)SCD3 in ~60% yield (Scheme 4-4).  
As shown in Figure 4-3, this GlxI-type reaction can be conveniently monitored by 
2H NMR, where PhC(O)CH(OH)SCD3 exhibits a 2H NMR signal at 1.88 ppm, and the 
product PhCH(OH)C(O)SCD3 has a signal at 2.13 ppm when referenced to an internal 
C6D6 standard (7.37 ppm). A third minor resonance at 2.38 ppm has been tentatively 
identified as indicating the presence of a non-coordinated anionic hemithioacetal-derived 
species in solution (vida infra). After 24 h, some unreacted hemithioacetal remains and 
the combined integrated intensity of the –SCD3 species has decreased by ~30%. This 
decrease appears to correlate with the formation of a dark orange-brown precipitate in the 
NMR tube. The chemical composition of this solid remains under investigation. It is 
insoluble in common organic solvents, thus precluding its characterization by solution 
spectroscopic methods. 
The anionic species (-SCD3, 2.38 ppm) can also be produced in dry acetonitrile by 
treatment of PhC(O)CH(OH)SCD3 with an equimolar amount of Me4NOH⋅5H2O. 
84 
Notably, no change in the 2H NMR spectral features of this mixture is identifiable after 
~18 h at room temperature, thus indicating that hemithioacetal isomerization to produce 
thioester does not occur in the presence of only Me4NOH⋅5H2O in acetonitrile in this 
time period. The 2H NMR studies of the reaction of 1 with PhC(O)CH(OH)SCD3 suggest 
that the hemithioacetal, thioester, and the spectroscopically observable anionic species do 
not directly coordinate to the Ni(II) center in 1. 
The integrated intensity of the combined -SCD3 signals remains constant for (a)-
(d) relative to the integrated intensity of a C6D6 internal standard. However, for (e) the 
integrated intensity of the combined -SCD3 species is reduced by ~30% relative to that 
 
 
Figure 4-3. 2H NMR spectra of a reaction mixture of 1 and PhC(O)CH(OH)SCD3 in dry 
CH3CN at various times after mixing. The first spectrum (a), which was obtained within 
5 minutes of mixing of the reagents, is taken as t = 0 min; (b) 19 min; (c) 43 min; (d) 83 
min; (e) 23 h 18 min.  
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found for (a)-(d). This appears to correlate with the appearance of a dark orange-brown 
precipitate in the reaction mixture. All spectra were recorded at 302 K. Opening of the 
spectral window to a chemical shift range of ~180 to -20 ppm did not reveal any 
additional signals. Specifically, the chemical shifts of the –SCD3 resonances of these 
molecules are identical to those found for the individual molecules in the absence of the 
paramagnetic Ni(II) complex. However, this is not conclusive evidence and does not rule 
out the possibility of transient interactions. 1H NMR was also used to monitor the 
reaction of 1 with PhC(O)CH(OH)SCH3 in CD3CN (Figure 4-4). During the time period 
required for the isomerization reaction at 302 K (~1.5 h as determined by the 2H NMR 
studies described above) the 1H NMR looks generally similar to that of analytically pure 
1, with only subtle broadening of selected resonances of 1. One new broad signal is 
present at ~32 ppm. This signal is not indicative of the presence of protonated amide 
complex 2, as it does not have a distinct resonance at this chemical shift (Figure 4-2). 
Opening of the chemical shift window to examine a range of 180 to -20 ppm, did not 
reveal any additional new resonances. Overall, the results of these NMR combined 
experiments suggest that the majority of the Ni(II) complex present in the hemithioacetal 
isomerization reaction mixture is unaltered 1.  
Control Reactions. Treatment of the protonated amide complex 
[(bppppa)Ni](ClO4)2 (2) with PhC(O)CH(OH)SCD3 (Scheme 4-4) resulted in no reaction  
after 18 h as determined by 2H NMR, thus indicating the requirement of the anionic 
chelate ligand in 1 for hemithioacetal isomerization reactivity. A deprotonated form of 
the ligand, Na(bppppa), does not promote hemithioacetal isomerization or deprotonation 
over a time period of ~40 h at 298 K, thus indicating the requirement of the Ni(II) center 
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Figure 4-4. (a) A region of the 1H NMR spectrum of 1. (b) The same region for 
compound 1 in the presence of an equimolar amount of PhC(O)CH(OH)SCD3. Both 
spectra were acquired in CD3CN at 302 K. 
 
for hemithioacetal isomerization reactivity. Treatment of 1 with an equimolar amount of 
the thioester PhCH(OH)C(O)SCD3 in dry acetonitrile at 302 K resulted in no reaction 
after 16 h. This suggests that the pKa value for the PhCH(OH)C(O)SCD3 proton of the 
thioester product must be significantly higher than the pKa value of the 
PhC(O)CH(OH)SCD3 proton of the hemithioacetal. Overall, the results of these 
combined studies suggest that 1 may serve as a general base for the hemithioacetal 
isomerization reaction. The basic site of 1 that accepts and subsequently distributes the 
proton may be either the amide oxygen or nitrogen. Because the bound amide oxygen 
atom is protected by the hydrophobic phenyl groups of the chelate ligand, as well as by 
the bulky t-butyl substituent, we favor a reaction pathway wherein the deprotonated 
amide nitrogen atom is involved in proton transfer reactivity. 
If 1 is acting as a general base for the hemithioacetal isomerization reaction, the 
reaction should be catalytic under appropriate conditions. To evaluate this possibility, an 
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NMR tube was prepared containing 1 and PhC(O)CH(OH)SCD3 in a 1:5 molar ratio and 
C6D6 (internal standard).  Spectroscopic monitoring of this reaction mixture using 2H 
NMR over the course of 66 h revealed the formation of ~1.5 equivalents of the thioester 
PhC(OH)C(O)SCD3. Overall, the spectra for this mixture were very similar to those 
shown in Figure 4-3, albeit a larger amount of the anionic 2.38 ppm species was present. 
Similar to the stoichiometric reaction, the combined integrated intensity of the –SCD3 
species decreased by ~37% after 66 h and a deep orange-brown precipitate deposited in 
the NMR tube. 
Evaluation of the Hemithioacetal Isomerization Reactivity of NiBr2·2H2O/1-
methylpyrrolidine in DMF using PhC(O)CH(OH)SCD3 and 2H NMR. There is one 
previous report in the literature of hemithioacetal isomerization promoted by NiBr2·2H2O 
and 1-methylpyrrolidine in DMF.11 No experimental details or yield were reported for 
this reaction. To gain insight into this reaction, we again used the 2H-labeled 
hemithioacetal and 2H NMR. Solutions were prepared containing an equimolar mixture 
of NiBr2·2H2O, PhC(O)CH(OH)SCD3 and C6D6 (internal standard) in dry DMF. 
Addition of one equivalent of 1-methylpyrrolidine to this mixture produced a color 
change from yellow-green to red-brown. 2H NMR spectra collected at various times 
following addition of the base are shown in Figure 4-5. Unlike the relatively simple 
spectra found for hemithioacetal isomerization promoted by 1 (Figure 4-3), several broad 
resonances in the 2H NMR spectra of the NiBr2·2H2O/1-methylpyrrolidine indicate the 
presence of multiple –SD3 containing species. For example, at least three new resonances 
are present in the region of 1.0-1.6 ppm.22 Another new resonance is also present at ~2.35 
ppm. We hypothesize that the more exposed Ni(II) center in NiBr2·2H2O, versus that 
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Figure 4-5. 2H NMR spectra of a reaction mixture of NiBr2·2H2O, 1-methylpyrrolidine 
and PhC(O)CH(OH)SCD3 in dry DMF at various times after mixing. The first spectrum 
(a), which was obtained within 10 minutes of mixing of the reagents, is taken as t = 0 
min; (b) 1.5 h; and (c) 23 h. The signals marked DMF are the natural abundance 2H NMR 
signals for protio DMF.23  
 
found in 1, allows for the formation of Ni(II) complexes with hemithioacetal-derived 
species. Over the course of 1.5 h, which is the time required for ~60% yield of thioester 
in the hemithioacetal isomerization reaction involving 1, only a trace amount of thioester 
is produced in the NiBr2•2H2O/1-methylpyrrolidine reaction (Figure 4-5(b)). 
Similar to the reaction involving 1, after ~1.5 h a heavy red-brown precipitate began to 
deposit in the NMR tube. At this point, the overall integrated intensity of the combined –
SCD3 species had decreased by 15%. After 24 h at 25 °C (Figure 4-5(c)), the amount of 
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thioester and hemithioacetal present in solution are similar, but the overall integrated 
intensity for all –SCD3 species has declined ~50%. 
 
Conclusions 
The glyoxalase pathway (Scheme 4-1) is ubiquitous in biological systems and the 
role of the metal center in the hemithioacetal isomerization catalyzed by Glx I remains to 
be fully defined. In 1970, Hall and Poet demonstrated that the conversion of model 
hemithioacetals to the corresponding α-hydroxy thioesters was accelerated in the 
presence of a divalent metal ion (e.g. Mg(II)).11 Specifically, the rate of thioester 
formation from a hemithioacetal was found to increase by 30-fold in a DMF solution 
containing Mg(NO3)2 and sodium acetate (or tertiary amines), versus a DMF solution 
containing only the base. The role of the Mg(II) center was proposed to be stabilization of 
an enediol(ate) intermediate. Similar reactivity was indicated to occur using other 
divalent metal ions (including Ni(II)) and bases, albeit no experimental details or yields 
were provided.11 Notably, in a later study involving an aqueous environment and using 
imidazole as the base, the rate of hemithioacetal isomerization was accelerated only by a 
factor of 1.8 in the presence of Mg(II).24 Under these conditions, water and imidazole 
likely compete as ligands for the Mg(II) center, thus limiting interactions between the 
metal and any anionic enediol(ate) intermediate. Overall, these studies represent the 
entirety of what has been previously reported in terms of metal-containing model studies 
relevant to the chemistry of Glx I enzymes.  The studies reported herein, although not of 
direct structural relevance to E. coli Glx I, provide interesting new insight into the 
chemistry of metal ion promoted hemithioacetal isomerization.  
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During attempts to prepare a mononuclear Ni(II)-OH complex of the amide-
appended bppppa ligand, we found that a deprotonated amide complex is produced. This 
type of reactivity has been recently identified in a structurally similar amide-appended 
Zn(II) complex.18 Stabilization of the deprotonated amide moiety occurs both through 
amide oxygen coordination to the divalent metal center and via delocalization of the 
anionic charge into the pyridyl ring. While exploration of the acid/base properties of 1 
and related compounds will be the subject of a future study, we hypothesize that the 
stabilization factors noted above produce an amide linkage having enhanced acidity.  
The reactivity of 1 with a hemithioacetal provides the first example of a well-
characterized Ni(II) complex which promotes a hemithioacetal isomerization reaction. 
Because the Ni(II) complex is paramagnetic, monitoring of this reaction was performed 
using a deuterium-labeled hemithioacetal and 2H NMR. This novel approach is also 
applicable to monitoring hemithioacetal isomerization reactions involving simple Ni(II) 
salts, as was outlined for the reaction involving NiBr2·2H2O and 1-methylpyrrolidine. 
Importantly, comparison of the reactions promoted by 1 and NiBr2·2H2O/1-
methylpyrrolidine provides clear evidence that the reaction involving the coordination 
complex is faster and involves fewer spectroscopically identifiable species. This is likely 
a consequence of the fact that while five coordination positions in 1 are occupied by the 
chelate ligand, the Ni(II) ion derived from NiBr2·2H2O in DMF has multiple available 
coordination positions for interaction with hemithioacetal-derived species. In terms of E. 
coli Glx I, the presence of four amino acid ligands to the Ni(II) center likely limits 
interaction with the hemithioacetal or anionic species derived from deprotonation of this 
substrate.  
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A problem encountered in using either 1 or NiBr2·2H2O/1-methylpyrrolidine is 
the precipitation of a red-brown solid in the reaction mixture after several hours. Based 
on the integrated intensity of the combined –SCD3 species in each reaction, this solid 
contains hemithioacetal-derived species. On-going efforts are focused on determining the 
chemical composition of this solid and its relevance to hemithioacetal isomerization 
reactivity.  
 
Experimental Section 
General Methods. All reagents were obtained from commercial sources and were 
used as received without further purification. Solvents were dried according to published 
procedures and were distilled under N2 prior to use.25 Water-sensitive reactions were 
performed in an MBraun Unilab glovebox under an atmosphere of purified N2. The 
organic compounds bppppa (N,N-bis[(6-phenyl-2-pyridyl)methyl]-N-[(6-pivaloylamido-
2-pyridyl)methyl]amine),17 PhC(O)CH(OH)SCD3 (hemithioacetal),21 and 
PhCH(OH)C(O)SCD3 (thioester)11 were prepared according to literature procedures. 
Physical Methods. 1H and 2H NMR spectra were collected as previously 
described.20 UV-vis spectra were recorded at ambient temperature using a Hewlett 
Packard 8453 diode array spectrophotometer. Solid-state IR spectra were recorded using 
a Shimadzu FTIR-8400 spectrometer as KBr pellets. Elemental analyses were performed 
by Atlantic Microlabs of Norcross, GA.  
CAUTION! Perchlorate salts of metal complexes with organic ligands are 
potentially explosive. Only small amounts of material should be prepared, and these 
should be handled with great care.26  
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[(bppppa–)Ni]ClO4·CH3OH (1). [(bppppa)Ni](ClO4)217 (26 mg, 0.032 mmol) 
dissolved in CH3CN (~2 mL) was added to a slurry of Me4NOH·5H2O (5.8 mg, 0.032 
mmol) in CH3CN (~2 mL). The resulting mixture was stirred under a dry nitrogen 
atmosphere for 4 h. The solvent was then removed under reduced pressure. The orange 
residue was dissolved in CH2Cl2 and the solution filtered through a glass wool/Celite 
plug. The CH2Cl2 was removed under reduced pressure. The remaining orange solid was 
recrystallized by Et2O diffusion into a CH3CN/CH3OH (2:1) solution to give deep 
orange-brown crystals  (15 mg, 68%). This reaction may be safely performed on a larger 
scale, starting with ~60 mg of [(bppppa)Ni](ClO4)2. Anal. Calcd for 
C35H34N5O5ClNiCH3OH: C, 59.24; H, 5.25; N, 9.60. Found: C, 58.79; H, 5.09; N, 9.64. 
UV-vis (CH3CN), nm (λmax, M -1cm -1): 440 (320); FTIR (KBr, cm-1): 1088 (νClO4), 628 
(νClO4).  
Monitoring Stoichiometric Hemithioacetal Isomerization by 2H NMR. A 
NMR tube containing equimolar amounts of 1 and PhC(O)CH(OH)SCD3 in dry protio 
acetonitrile (700 µL) was prepared under a nitrogen atmosphere. An internal standard 
(C6D6, 1 µL) was added and the tube was sealed using a stopcock. The tube was then 
quickly transferred to the NMR system that had been previously optimized for data 
collection. Each 2H NMR spectrum was referenced to the chemical shift of the C6D6 
standard. The C6D6 signal was also used as an internal integration standard.  
Na(bppppa). The bppppa ligand (27 mg, 4.9 x 10-5 mol) was treated with NaH 
(1.2 mg, 5.1 x 10-5 mol) in dry THF. After stirring for 1.5 h at ambient temperature, the 
solvent was removed under reduced pressure and a 1H NMR spectrum of the remaining 
pasty solid was obtained. 1H (CD3CN, 300 MHz) δ 8.00-7.75 (br m, 7H), 7.64 (br d, J = 
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7.8 Hz, 3H), 7.60-7.45 (br m, 6H), 7.50-7.30 (br m, 2H), ~6.6 (br, 1H), 3.79 (s, 4H), 3.65 
(s, 2H), 1.03 (s, 9H). These resonances are shifted relative to those found for neutral 
bppppa.17 Addition of water to Na(bppppa) in acetonitrile yields the neutral bppppa 
ligand, as determined by 1H NMR.  
Treatment of Na(bppppa) with PhC(O)CH(OH)SCD3 in Protio Acetonitrile. 
This reaction was set up and monitored by 2H NMR in an identical fashion to that 
employed for 1. No evidence for hemithioacetal isomerization or deprotonation was 
found over a time period of ~40 h at 298 K. 
Hemithioacetal Reactions involving NiBr2⋅2H2O and 1-methylpyrrolidine. A 
solution of NiBr2⋅2H2O (10 mg, 3.9 x 10-5 mol) in DMF (700 µL) was prepared. Stirring 
of this solution for ~30 minutes at room temperature was required for the NiBr2⋅2H2O to 
fully dissolve. To this solution was added the internal standard C6D6 (1 µL), the 
hemithioacetal PhC(O)CH(OH)SCD3 (7.3 mg, 3.9 x 10-5 mol) and 1-methylpyrrolidine 
(4.5 µL, 3.9 x 10-5 mol). The resulting red-brown mixture was transferred to an NMR 
tube that was sealed using a stopcock. This tube was transferred within 10 min to the 
NMR instrument that had been previously optimized for data collection. 2H NMR spectra 
were collected at timed intervals and were referenced to the chemical shift of the C6D6 
internal standard (7.37 ppm). Reactions of this type were monitored for a minimum of 24 
h at 298 K. After approximately 40 min, the color of the solution had intensified and a 
red-brown precipitate began to appear. Subtle loss of color and an increasing amount of 
precipitate are apparent over the course of the reaction. The integrated intensity of all –
SCD3 labeled species in the reaction mixture decreases by ~50% after 24 h. As a prelude 
to evaluating the results of these experiments, individual 2H NMR spectra of the 
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hemithioacetal PhC(O)CH(OH)SCD3 (1.97 ppm) and thioester PhC(OH)CH(O)SCD3 
(2.11 ppm) were collected in DMF. 
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CHAPTER 5  
A TRINUCLEAR Ni(II) ENEDIOLATE COMPLEX: SYNTHESIS, 
CHARACTERIZATION, AND DIOXYGEN  REACTIVITY1 
 
Abstract 
 Using a new N4-donor chelate ligand having a mixture of hydrophobic phenyl and 
hydrogen bond donor appendages, a trinuclear Ni(II) complex of the doubly deprotonated 
form of 2-hydroxy-1,3-diphenylpropane-1,3-dione was isolated, characterized (X-ray 
crystallography, elemental analysis, UV-vis, 1H NMR, FTIR, magnetic moment 
measurement), and evaluated for O2 reactivity. This complex, [(6-NA-6-Ph2TPANi)2(µ-
PhC(O)C(O)C(O)Ph)2Ni](ClO4)2 (4), has two terminal pseudo octahedral Ni(II) centers 
supported by the tetradentate chelate ligand, and a central square planar Ni(II) ion ligated 
by oxygen atoms of two bridging enediolate ligands. In CH3CN, 4 exhibits a deep 
orange/brown color and λmax = 463 nm (ε = 16,000 M-1cm-1). The room temperature 
magnetic moment of 4, determined by Evans method, is µeff = 5.3(2) µB. This is consistent 
with the presence of two non-interacting high-spin Ni(II) centers, a diamagnetic central 
Ni(II) ion, and an overall quintet ground state. Exposure of a CH3CN solution of 4 to O2 
results in the rapid loss of the orange/brown color to give a green solution. The products 
identified from this reaction are [(κ3-6-NA-6-Ph2TPA)Ni(O2Ph)(H2O)]ClO4 (5), benzil 
(PhC(O)C(O)Ph), and CO. Identification of 5 was achieved via its independent synthesis 
and comparison of its 1H NMR and mass spectral features with those of the 6-NA-6- 
                                                 
1Coauthored by Katarzyna Rudzka, Atta M. Arif, and Lisa M. Berreau. Reproduced with 
permission from Inorg. Chem. 2008, 47, ASAP 10/29/08. Copyright American Chemical 
Society. 
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Ph2TPA-containing product generated upon reaction of 4 with O2. The independently 
prepared sample of 5 was characterized by X-ray crystallography, elemental analysis, 
UV-vis, mass spectrometry, and FTIR. The O2 reactivity of 4 has relevance to the active 
site chemistry of Ni(II)-containing acireductone dioxygenase (Ni(II)-ARD).  
 
Introduction 
Acireductone dioxygenase (ARD) enzymes are found in variety of species, 
including humans.1-7 They are associated with the methionine salvage pathway wherein 
they catalyze O2-dependent oxidative aliphatic carbon-carbon bond cleavage reactions 
involving an acireductone intermediate.1 The enzymes Ni(II)-ARD and Fe(II)-ARD’, 
which have the same protein component and differ only in the active site metal ion, have 
been shown to catalyze different reactions of the acireductone intermediate in Klebsiella 
oxytoca ATCC 8724. As shown in Scheme 5-1, the reaction catalyzed by Ni(II)-ARD is a 
shunt out of the methionine salvage pathway and gives carboxylic acids and CO as 
products. Carbon monoxide production via a similar reaction has also been identified in 
Bacillus subtilis and E. coli.8,9 The reaction catalyzed by Fe(II)-ARD’ gives a α-ketoacid 
product that is a precursor to methionine in an “on-pathway” type reaction. It is important 
to note that the activities of Ni(II)-ARD and Fe(II)-ARD’ can be interconverted by 
exchange of the metal ion.10 
A recently deposited X-ray structure of a putative ARD from mouse (MmARD, 
PDB 1VR3)11, combined with NMR structural studies (PDB 1ZRR), conserved domain 
homology modelling, and X-ray absorption spectroscopic studies of K. oxytoca Ni(II)-
ARD, indicate that the Ni(II) center in this enzyme is ligated by a facial array of three 
histidine residues and a glutamate ligand from the protein.12-14 The two remaining 
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coordination positions of the Ni(II) center are occupied by water/hydroxide ligands in the 
resting state. A histidine residue may be displaced from the Ni(II) complex in the ES 
complex.15 The structural studies also revealed several important secondary residues that 
are located near the active site Ni(II) center. These include Phe92, Phe142, Arg104, and 
Arg154 in K. oxytoca Ni(II)-ARD. The phenylalanine residues have been proposed to 
orient the substrate for reaction with O2 and are close enough to exhibit paramagnetically 
shifted resonances.12 Arg104 and Arg154 have been suggested to play a role in 
stabilizing substrate coordination via hydrogen bonding and/or may donate or accept a 
proton.12,13 In Ni(II)-ARD a 1,3-coordination motif is proposed for the acireductone 
dianion (Scheme 5-1) in the enzyme/substrate complex.16,17  In this binding mode, Lewis 
acid activation of the C(1)-O(1) and C(3)-O(3) units is proposed to favor the formation of 
a five-membered cyclic peroxide upon reaction with oxygen. Breakdown of this peroxide 
ring would then lead to the formation of the carboxylic acids and CO (Scheme 5-1).  
 
 
Scheme 5-1. Oxidative cleavage of acireductone catalyzed by acireductone dioxygenase 
enzymes (Ni(II)-ARD and Fe(II)-ARD’).  
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Figure 5-1. (a) Proposed structure of acireductones. (b) X-ray crystallographically 
determined structures of the neutral form and rubidium salt of triose reductone. (c) An X-
ray crystallographically characterized complex having acireductone dianion coordination 
to a transition metal. 
 
There is currently very little known about the coordination chemistry of 
acireductones and the O2 reactivity of M(II)-acireductone species. As shown in Figure 5-
1(a), neutral acireductones have been proposed to adopt structures involving a six-
membered ring.18 However, the X-ray structure of the rubidium salt and neutral form of 
triose reductone (R = R’ = H) revealed that all three oxygen atoms are positioned on one 
side of the carbon chain (Figure 5-1(b)).19,20 Prior to 2005, one transition metal 
compound having a coordinated acyclic acireductone ligand had been characterized by 
X-ray crystallography. This compound, [(Ru(bipy)2)2(µ-C4H4O3)](PF6)2 (Figure 5-1(c)), 
was generated as a byproduct in reactions of [Ru(bipy)2Cl2⋅2H2O] in ethylene glycol in 
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the presence of NH4PF6.21 Similar to the triose reductone structures, the acireductone 
ligand in [(Ru(bipy)2)2(µ-C4H4O3)](PF6)2 is coordinated with all three oxygen atoms of 
the enediolate on the same side of the carbon chain. Similar backbone carbon-carbon 
distances, and C(1)-O and C(3)-O bonds (1.29 and 1.30 Å, respectively) that are shorter 
than the C(2)-O bond (1.39 Å), indicate a delocalized enolate anion along the carbon 
backbone. No O2 reactivity studies have been reported for this complex.  
Of relevance to Ni(II)-ARD, we generated a Ni(II) cis-β-keto-enolate complex, 
[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (1, Scheme 5-2) which can be isolated and 
characterized.22 Treatment of 1 with one equivalent of base followed by the introduction 
of O2 results in the formation of a Ni(II) carboxylate complex, [(κ3-6-
Ph2TPA)Ni(O2CPh)2(H2O)] (2), and CO, as well as benzil (PhC(O)C(O)Ph). The 
formation of carboxylates and CO, as well as 18O incorporation into one oxygen atom of 
each carboxylate ligand, is consistent with an ARD-type pathway. However, the 
formation of benzil suggests that an alternative reaction pathway is also operative.  
Complex 1 undergoes reaction with O2 in the absence of excess base to give a Ni(II) 
monobenzoate complex [(6-Ph2TPA)Ni(O2CPh)]ClO4 (3), CO, benzil (PhC(O)C(O)Ph), 
and other phenyl-containing organic byproducts.23 From these combined studies we 
found that the O2 reaction is cleaner, with a higher level of 18O incorporation in the 
benzoate product, under conditions wherein the acireductone ligand can access a 
dianionic form as is proposed to occur in the Ni(II)-ARD catalyzed reaction. Our initial 
approach toward modeling the active site chemistry of Ni(II)-ARD, as outlined in 
Scheme 5-2,  was to use a tetradentate nitrogen donor ligand having two hydrophobic 
phenyl appendages (6-Ph2TPA). The phenyl groups were included to create a 
102 
 
hydrophobic microenvironment that could have relevance to the possible role of active 
site phenylalanine side chains in Ni(II)-ARD. To model the acireductone ligand we have 
used the deprotonated form of 2-hydroxy-1,3-diphenylpropan-1,3-dione.  
 In the research outlined herein we present the Ni(II) coordination chemistry of a 
new chelate ligand wherein a secondary amine hydrogen bond donor has been 
incorporated to create a mixed hydrophobic/hydrogen bond donor microenvironment. 
This ligand, 6-NA-6-Ph2TPA (Figure 5-2), is the reduced form a previously reported 
amide-containing ligand.24 Having a rigidly fixed hydrogen bond donor, the 
 
 
Scheme 5-2. O2-dependent chemistry of [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4. 
 
 
Figure 5-2. The 6-NA-6-Ph2TPA chelate ligand. 
103 
 
6-NA-6-Ph2TPA ligand is appropriate for investigating the influence of a single hydrogen 
bond donor on the chemistry of Ni(II) enolate or enediolate complexes. This 
investigation is relevant to evaluating the possible influence of hydrogen bonding 
involving an arginine side chain with a Ni(II)-coordinated acireductone in the Ni(II)-
ARD enzyme/substrate complex. Our results outlined herein demonstrate that use of the 
6-NA-6-Ph2TPA ligand enables the isolation and characterization of a trinuclear Ni(II) 
complex, [(6-NA-6-Ph2TPANi)2(µ-PhC(O)C(O)C(O)Ph)2Ni](ClO4)2 (4), wherein two 
enediolate ligands derived from 2-hydroxy-1,3-diphenylpropan-1,3-dione bridge between 
terminal pseudo octahedral Ni(II) centers and a central square planar Ni(II) ion (Scheme 
5-3). Complex 4, which is the first structurally characterized example of a Ni(II)-
enediolate complex of relevance to Ni(II)-ARD, reacts with O2 to yield a 6-NA-6-
Ph2TPA-ligated Ni(II) benzoate complex, CO, benzil (PhC(O)C(O)Ph), and a nickel 
benzoate species.  
 
    
Scheme 5-3. Synthesis of [(6-NA-6-Ph2TPANi)2(µ-PhC(O)C(O)C(O)Ph)2Ni](ClO4)2(4). 
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Experimental Section 
General. All reagents and solvents were purchased from commercial sources and 
used as received unless otherwise noted. Acetonitrile and diethyl ether were dried 
according to published procedures.25 Air sensitive reactions were performed in a MBraun 
Unilab glovebox or a Vacuum Atomospheres MO-20 glovebox under an atmosphere of 
purified N2. 18O2 was purchased from Icon Services, Summit, NJ. The ligand precursors 
2-(pivaloylamido)-6-(aminomethyl)pyridine, 2-(chloromethyl)-6-phenylpyridine 
hydrochloride, and 2-hydroxy-1,3-diphenylpropan-1,3-dione were prepared according to 
literature procedures.26-28 Qualitative CO detection was performed using the PdCl2 
method.29 
Physical Methods. 1H NMR spectra were recorded on a Bruker ARX 400 
spectrometer with the spectra for 4 and 5 being recorded under conditions as previously 
described.30 Chemical shifts (δ) are referenced to the residual solvent peak in CD2HCN 
(1H: 1.94 ppm). UV-vis spectra were recorded on a Hewlett-Packard 8453 diode array 
spectrophotometer. FTIR spectra were recorded on a Shimadzu FTIR-8400 spectrometer. 
Mass spectrometry experiments were performed at the University of California, 
Riverside. Room temperature magnetic susceptibilities were determined by the Evans 
method.31 Elemental analyses were performed by Canadian Microanalytical, Service, 
Inc., British Columbia or Atlantic Microlabs, Inc., Norcross, GA.  
Caution! Perchlorate salts of metal complexes supported by organic ligands are 
potentially explosive.32 
2-(neopentylamino)-6-(aminomethyl) pyridine. LiAlH4 (1.02 g, 0.0268 mol) 
was added to 50 mL of freshly distilled Et2O and the resulting slurry was stirred under N2 
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for ~10 min. This mixture was then added dropwise to 2-(pivaloylamido)-6-
(aminomethyl)pyridine (0.69 g, 0.0033 mol). The resulting mixture was stirred at room 
temperature for 24 hours. Distilled water (75 mL) was then added, with the first 10 mL 
being added dropwise.  The solution was then filtered and the filtrate was extracted with 
ethyl acetate (3x50 mL), the combined organic fractions were dried over Na2SO4, and the 
solvent was removed under reduced pressure, yielding a pale yellow oil (0.58, 90%). 1H 
NMR (CD3CN, 400 MHz) δ 7.32 (t, J = 7.7 Hz, 1H), 6.46 (d, J = 7.2 Hz, 1H), 6.31 (d, J 
= 8.3 Hz, 1H), 5.02 (br, 2H), 3.61 (s, 2H), 3.15 (d, J = 6.4 Hz, 2H), 0.94 (s, 9H) ppm.  
6-NA-6-Ph2TPA. 2-(neopentylamino)-6-(aminomethyl)pyridine (0.58 g, 3.0 x 10-
3 mol), 2-(chloromethyl)-6-phenylpyridine hydrochloride (1.44 g, 6.00 x 10-3 mol), 
Na2CO3 (3.18 g, 3.01 x 10-2 mol), and a catalytic amount of TBABr were combined in 
CH3CN (150 mL). This mixture was refluxed under a N2 atmosphere for 20 h. After 
cooling to room temperature, the reaction mixture was added to an equal volume of 1 M 
NaOH. Extraction with CH2Cl2 (3 x 80 mL) followed by drying of the combined organic 
fractions over Na2SO4 and removal of the solvent under reduced pressure yielded a 
yellow-brown oil. Purification by column chromatography (silica gel, 230-400 mesh; 
ethyl acetate/hexanes 1:1) gave the product as a yellow oil (1.2 g, 74%). 1H NMR 
(CD3CN, 400 MHz) δ 8.05 (d, J = 8.5 Hz, 4H), 7.78 (t, J = 8Hz, 2H), 7.69 (d, J = 7.7 Hz, 
2H), 7.63 (d, J = 7.7 Hz, 2H), 7.49-7.41 (m, 6H), 7.36 (m, 1H), 6.78 (d, J = 7.2 Hz, 1H), 
6.35 (d, J = 8.3 Hz, 1H), 5.02 (br, 1H), 3.98 (s, 4H), 3.73 (s, 2H), 3.18 (d, J = 6.4 Hz, 
2H), 0.94 (s, 9H) ppm; 13C{1H} NMR (CD3CN, 100 MHz) δ 160.9, 160.4, 158.5, 157.0, 
140.5, 138.4, 129.7, 127.8, 122.5, 119.5, 111.8, 106.7, 61.0, 60.9, 53.5, 33.0, 27.9 (19 
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signals expected, 18 observed; overlap of two resonances in aromatic region); FTIR 
(KBr, cm-1) 3400 (νN-H).  
[(6-NA-6-Ph2TPANi)2(µ-PhC(O)C(O)C(O)Ph)2Ni](ClO4)2 (4) To a solution of 
6-NA-6-Ph2TPA (0.042 g, 0.080 mmol) in CH3CN (2 mL) was added a CH3CN solution 
(2 mL) of Ni(ClO4)2·6H2O (0.044 g, 0.12 mmol) and PhC(O)CH(OH)C(O)Ph (0.019 g, 
0.080 mmol). After 15 min of stirring, this mixture was transferred to a new vessel 
containing Me4NOH·5H2O (0.029 g, 0.16 mmol). The solution was stirred for 3 h at room 
temperature under a nitrogen atmosphere after which the solvent was removed under 
reduced pressure and the residue was redissolved in CH2Cl2, filtered, and the filtrate 
reduced to ~1 mL. Addition of excess Et2O (~15 mL) resulted in the precipitation of an 
orange-brown solid that was collected and dried under vacuum. Long needles were 
obtained by Et2O diffusion into a CH2Cl2 solution of 4 (29 mg, 38%). Crystals suitable 
for X-ray crystallography were obtained by Et2O diffusion into an acetonitrile/methanol 
solution of 1. Anal calcd. for C100H94N10O14Ni3Cl2⋅0.66CH2Cl2: C, 61.58; H, 4.89; N, 
7.13. Found: C, 61.50; H, 4.83; N, 6.75 (The presence of methylene chloride in the 
sample was confirmed by 1H NMR). UV-vis, nm (ε, M-1cm-1) 463 (16,000); µeff = 5.3(2) 
µB; FTIR (KBr, cm-1) 3411 (br, νN-H), 1096 (νClO4), 624 (νClO4).  
Independent synthesis of [(6-NA-6-Ph2TPA)Ni(O2CPh)(H2O)]ClO4 (5). A 
solution of 6-NA-6-Ph2TPA (0.028 g, 0.052 mmol) in CH2Cl2 was added to solid 
Ni(ClO4)2·6H2O (0.019 g, 0.052 mmol). To this slurry was added a methanol solution of 
sodium benzoate (0.0075 g, 0.052 mmol). The resulting green solution was stirred for 1.5 
h at room temperature. The solvent was then removed under reduced pressure. The green 
residue was redissolved in CH2Cl2, filtered, and the filtrate was brought to dryness under 
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vacuum. The solid was dissolved in methanol and this solution was added to an equal 
volume of water. Slow evaporation of this mixture produced green crystals (0.029 g, 
68%). Anal Calcd. for C42H44N5O7NiCl: C, 61.22; H, 5.39; N, 8.50. Found: C, 60.89; H, 
5.44; N, 8.36. UV-vis, nm (ε, M-1cm-1) 600 (19), 1004 (18); FTIR (KBr, cm-1) 3360 (νN-
H), 1092 (νClO4), 621 (νClO4); FAB-MS MeOH:NBA, m/z (relative intensity) 706 ([M-
ClO4-H2O]+, 100%).  
Product isolation and identification following the reaction of 4 with 18O2. 
Compound 4 (57 mg, 0.030 mmol) was dissolved in CH3CN (10 mL). It was degassed by 
two freeze/pump/thaw cycles and was then exposed to 18O2 and stirred for 12 h at room 
temperature. This resulted in the formation of a pale green reaction mixture. After 
removal of the solvent under reduced pressure, to the remaining solids was added 
hexanes:ethyl acetate (4:1 mixture) and then CH3CN dropwise until all solids had 
dissolved. The mixture was then transferred to a silica gel column and fractions were 
collected. Using hexanes:ethyl acetate (4:1) benzil (PhC(O)C(O)Ph) was eluted from the 
column. This product was identified by 1H NMR and GC-MS. The yield of benzil from 
this reaction was consistently ~20% based on the formulation that one benzil molecule 
can form from each enediolate ligand of 4. A control reaction indicated that an 
independent sample of benzil was recovered in ~85% yield using the column conditions 
outlined above.  
Switching of the solvent to pure acetonitrile resulted in the elution of a pale green 
band. Removal of the solvent from this fraction and analysis by 1H NMR indicated the 
presence of [(6-NA-6-Ph2TPA)Ni(O2CPh)(H2O)]ClO4 (5) as the signals of this product in 
the 30-70 ppm region exactly matched those obtained for the independently prepared 5. 
108 
 
The isolated yield of this product from the column was variable (~50-75% based on 
producing two equivalents of 5 from each equivalent of 4). A control reaction indicated 
that an independent sample of 5 was recovered in ~75% yield using the column 
conditions outlined above. Thus a portion of 5 is lost during the chromatographic 
separation. These combined results suggest that 5 is produced in nearly quantitative yield 
in the reaction of 4 with O2, which is consistent with 1H NMR spectra of the reaction 
mixture (Figure 5-5(b)). Switching of the column eluent to MeOH resulted in the elution 
of a yellow material. Following removal of the solvent under reduced pressure the pale 
yellow material was evaluated using 1H NMR and FTIR. The 1H NMR spectrum did not 
contain any resonances in the paramagnetically-shifted region beyond 10 ppm, only 
broad peaks overlapping a few sharp resonances in the 5-8 ppm region. The infrared 
spectrum of the solid yellow material shows carboxylate vibrations at 1554 (νas(COO-)) and 
1405 cm-1 (νs(COO-)), respectively, and phenyl group vibrations at 1598 cm-1 and 717 cm-1. 
These combined results are consistent with the yellow compound being a Ni(II) benzoate 
species, such as Ni(O2CPh)2⋅nCH3OH. Attempts were made to characterize this yellow 
compound using mass spectrometry methods (FAB and MALDI). Unfortunately, this 
material, which has limited solubility in organic solvents, did not give clear spectral 
evidence for a particular formulation. The data from both methods exhibited only low 
intensity m/z peak envelopes (e.g <20% intensity relative to the peaks present for the 
nitrobenzylacohol matrix in the FAB-MS spectrum) that could not be conclusively 
identified.  
X-ray Crystallography. Single crystals of 4·2Et2O·3CH3CN and 5⋅CH3OH 
were each  mounted on a glass fiber with traces of viscous oil and then transferred to a 
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Nonius KappaCCD diffractometer (Mo Kα, λ = 0.71073 Å). Ten frames of data were 
collected with an oscillation range of 1 deg/frame and an exposure time of 20 sec/frame. 
Indexing and unit cell refinement based on all observed reflections from those ten frames 
indicated a monoclinic C lattice for 4·2Et2O·3CH3CN and a monoclinic P lattice for 
5⋅CH3OH. A total of 17358 reflections for 4·2Et2O·3CH3CN and 17258 reflections for 
5⋅CH3OH were indexed, integrated and corrected for Lorentz, polarization, and 
absorption effects using DENZO-SMN and SCALEPAC.33 The structure was solved by a 
combination of direct methods and heavy atom using SIR97.34 All of the non-hydrogen 
atoms of 4·2Et2O·3CH3CN and 5⋅CH3OH were refined with anisotropic displacement 
coefficients. The N(1)-H in 4·2Et2O·3CH3CN was located and refined independently. 
All other hydrogen atoms were assigned isotropic displacement coefficients U(H) = 
1.2U(C) or 1.5U(Cmethyl) and their coordinates were allowed to ride on their respective 
carbons using SHELXL97.35 One perchlorate anion and the t-butyl methyl group exhibit 
disorder in 4·2Et2O·3CH3CN. The perchlorate anion in 5⋅CH3OH exhibits disorder.  
 
Results and Discussion 
Acireductone dioxygenases are fascinating metalloenzymes. The Ni(II)-ARD and 
Fe(II)-ARD’ enzymes represent the only example in biology wherein the simple change 
of a metal ion results in a different chemical reaction. The key issue that is proposed to 
determine ARD vs. ARD’ reactivity is the coordination mode of the acireductone on the 
divalent metal center. Metal-centered reactivity with O2 is not proposed in these systems. 
Instead, direct reaction between the coordinated acireductone and O2 is proposed to result 
in the formation of a 4- or 5-membered peroxide species involving the acireductone from 
which the ARD and ARD’ products are generated, respectively.  
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Synthesis. A goal of our work is to prepare and characterize examples of divalent 
metal complexes of acireductone-type ligands and examine their reactivity with O2. A 
recent Cambridge Crystallographic Database search (v. 5.29 updated Jan. 2008) revealed 
that structurally characterized examples of transition metal complexes having a acyclic 
acireductone-type ligand remain rare,36 with the only examples to our knowledge being 
[(Ru(bipy)2)2(µ-C4H4O3)](PF6)2 (Figure 5-1(c)) and [(6-
Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (1, Scheme 5-2). In the diruthenium complex 
the acireductone is coordinated as a dianion in a coordination motif akin to that found in 
the neutral and rubidium salt forms of triose reductone (Figure 5-1). Complex 1 contains 
a cis-β-keto enolate-type ligand of the monodeprotonated form of 2-hydroxy-1,3-
diphenylpropan-1,3-dione (Scheme 5-2). The different coordination modes of these 
acireductone-type ligands could be due to their structural differences and/or the 
protonation level. Our investigations with the 6-NA-6-Ph2TPA ligand started with an 
attempt to prepare an analog of 1 wherein one oxygen atom of the coordinated 
acireductone-type ligand could form a hydrogen bonding interaction with the neopentyl 
substituent of the chelate ligand. From a reaction mixture comprised of a 1:1:1:1 
stoichiometry (6-NA-6-Ph2TPA, Ni(ClO4)2⋅6H2O, Me4NOH⋅6H2O, 2-hydroxy-1,3-
diphenylpropane-1,3-dione) of reagents we obtained a few small orange-brown needle-
type crystals. This material was identified by single crystal X-ray crystallography as the 
trinuclear complex [(6-NA-6-Ph2TPANi)2(µ-PhC(O)C(O)C(O)Ph)2Ni](ClO4)2 (4). The 
production of 4 under these conditions is interesting as it suggests that the presence of the 
internal hydrogen bond donor may be important toward promoting dianion coordination. 
Adjustment of the reaction stoichiometry to that required for the formation of the 
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trinuclear 4 (Scheme 5-3) gave an orange-brown crystalline solid in 38% overall yield. 
This relatively low yield appears to be due in part to the presence of at least one 
additional product in this reaction mixture as indicated by 1H NMR. 
X-ray Crystallography. A drawing of the cationic portion of 4·2Et2O·3CH3CN 
is shown in Figure 5-3(a). The two terminal pseudo octahedral Ni(II) centers are 
equivalent via a C2 rotation. A drawing of the trinuclear core and metal coordinated 
atoms in 4·2Et2O·3CH3CN are shown in Figure 5-3(b), with the full ligand environments 
of the pseudo octahedral and square planar Ni(II) centers being shown in Figure 5-3(c) 
and 5-3(d). Details of the X-ray data collection and refinement are given in Table 5-1. 
Selected bond distances and angles are given in Table 5-2.  
 The Ni(1) center exhibits a pseudo octahedral coordination geometry. The Ni-N 
bonds vary in length over a range of ~0.3 Å, with the shortest Ni-N distance involving 
the tertiary amine donor of the chelate ligand (Ni(1)-N(3) 2.039(3) Å). The longest Ni-N 
distance is found for one of the two phenyl-appended pyridyl donors (Ni(1)-N(4) 
2.341(3) Å). A survey of the Ni(II) complexes reported to date of chelate ligands 
containing an aryl-appended pyridyl donor indicates that a range of Ni-NPhPy distances 
(2.15-2.36 Å) are possible depending on the other ligands present on the metal 
center.22,23,27,30,37,38 The Ni(1)…Ni(2) distance is 3.73 Å.  
The enediolate ligand in 4·2Et2O·3CH3CN is coordinated as a cis bridging 
ligand between Ni(1) and Ni(2), forming two five-membered chelate rings. This 
coordination motif is similar to that found in the rubidium salt and neutral form of triose 
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Figure 5-3. Thermal ellipsoid drawings (50% probability) of the cationic portion of 
4·2Et2O·3CH3CN. (a) Full cation;  (b) trinuclear metal core; (c) the pseudo octahedral 
Ni(1) center; and (d) the square planar Ni(2) center. Hydrogen atoms except the 
neopentylamine proton have been omitted for clarity. 
 
reductone (Figure 5-1) and in [(Ru(bipy)2)2(µ-C4H4O3)](PF6)2.19-21 The Ni(1)-O distances 
differ only slightly, with the axial Ni(1)-O(1) distance being ~0.07 Å shorter than the 
bridging Ni(1)-O(2) bond length. The square planar Ni(II) center has shorter Ni-O bonds 
(~1.86 Å). The five-membered chelate ring of the enediolate results in a O(2)-Ni(2)-O(3) 
bond angle (85.77(11)°) that is acute relative to the O(3)#1-Ni(2)-O(2) angle 
(94.20(11)°). The C(36)-O(1) (1.287(5) Å) and C(38)-O(3) (1.310(4) Å) bond distances 
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are shorter than the C(37)-O(2) (1.380(5) Å) bond indicating more single bond character 
in the latter. This is consistent with a localized anion at O(2) and a delocalized enolate 
anion in the O(1)-C(36)-C(37)-C(38)-O(3) backbone. Finally, at the Ni(1) site, O(1) 
accepts a hydrogen bond from the neopentylamine moiety of the chelate ligand 
((N(1)…O(1) 2.838(5) Å; N(1)-H(1)…O(1) 163(5)°). These parameters are consistent 
with the presence of a moderate hydrogen bonding interaction.39  
Overall, the isolation and structural characterization of 4 reveals that the 
enediolate form of the coordinated acireductone-type ligand can be stabilized via the 
recruitment of an additional Ni(II) center, with a contribution from a hydrogen bonding 
interaction. Stabilization of a Ni(II)-coordinated acireductone dianion species in the 
active site of Ni(II)-ARD is proposed to involve hydrogen bonding interactions with one 
or more arginine residues.1 
Spectroscopic Properties. The solid-state infrared spectrum of 4 in KBr contains 
a broad, intense feature at ~3420 cm-1 for the neopentylamine N-H moiety. Vibrations at 
1096 and 623 cm-1 are consistent with the presence of the perchlorate anions. 
The UV-vis spectrum of 4 in CH2Cl2 (Figure 5-4) contains a broad absorption 
band at 463 nm (ε = 16,000 M-1cm-1; Figure 5-4). This spectrum is notably distinct from 
that exhibited by 1 (λmax = 399 nm (ε = 6800 M-1cm-1) in CH2Cl2).23 The intensity of the 
absorption band in 4 is consistent with a charge transfer type transition. 
The 1H NMR spectrum of 4 contains several distinct paramagnetically shifted 
resonances in the region of 20-70 ppm (Figure 5-5(a)). Assignments of individual 
resonances in this region have not been made, as the method typically employed to 
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conclusively identify such signals (2D-COSY) 30 is not feasible due to the broad nature of 
several of the signals. 
 Pseudo octahedral high-spin Ni(II) centers each have two unpaired spins and the 
central Ni(II) is diamagnetic. The observed magnetic moment is slightly higher than the 
spin-only value predicted for this electronic structure (µso = 4.9 µB), which could be due 
to orbital contributions to the magnetic moment.  
O2 Reactivity of 4. Product Identification. Exposure of an acetonitrile solution 
of 4 to O2 results in the rapid loss of the orange-brown color to give a pale green solution. 
The overall reaction that takes place is shown in Scheme 5-4. The methods used for 
product identification and/or isolation are outlined below. 
Analysis of the products generated in the reaction of 4 with O2 by 1H NMR 
revealed the presence of several new resonances in the region of 20-70 ppm (Figure 5- 
6(b)). Mass spectroscopic analysis of the mixture revealed a parent ion at m/z 706. The 
complex associated with this 1H NMR spectrum and parent ion was identified via the 
independent synthesis as [(6-NA-6-Ph2TPA)Ni(O2CPh)(H2O)]ClO4 (5). This compound 
was prepared via admixture of equimolar amounts of 6-NA-6-Ph2TPA, Ni(ClO4)2⋅6H2O, 
and sodium benzoate in wet CH2Cl2/MeOH. Recrystallization of the product from 
MeOH/water yielded 5 as green crystals in 68% yield. The independently synthesized 
complex has been characterized by X-ray crystallography, elemental analysis, FTIR, 
mass spectrometry, and UV-vis. Compound 5 can be isolated from the reaction mixture 
of 4 with O2 in ~50-75% yield by column chromatography. A less than stoichiometric 
amountis isolated due to the conditions employed (column chromatography) for 
separation of 4 from the other reaction products. 
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Table 5-1. Summary of X-ray data collection and refinement for 4·2Et2O·3CH3CN and 
5⋅CH3OH 
 4·2Et2O·3CH3CN 5⋅CH3OH 
empirical formula C114H123N13O16Ni3Cl2 C43H48N5O8NiCl
formula weight 2178.28 857.02
crystal system Monoclinic Monoclinic
space group C2/c P21/n
a (Å) 24.4466(8) 11.6202(3)
b (Å) 18.6303(7) 23.7494(4)
c (Å) 23.8127(7) 15.1919(4)
a (deg) 90 90
b (deg) 96.160(2) 95.9420(11)
g (deg) 90 90
V (Å3) 10782.8(6) 4170.03(17)
Z 4 4
dcalcd, Mg m-3 1.342 1.365 
temp (K) 150(1) 150(1)
crystal size (mm3) 0.23 x 0.13 x 0.08 0.30 x 0.25 x 
diffractometer Nonius KappaCCD Nonius KappaCC
abs. coeff. (mm-1) 0.639 0.588
2θ max (deg) 50.72 54.96
reflections 17358 17258
indep. reflections 9891 9480
variable parameters 721 685
R1 / wR2b 0.0582/0.1174 0.0643/0.1487
goodness-of-fit (F2) 1.043 1.042
largest diff. (e Å-3) 0.609, -0.638 1.304, -1.026
aRadiation used: Mo Kα (λ = 0.71073 Å). bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|;  
wR2 = [∑[w(Fo2-Fc2)2]/[∑(Fo2)2]]1/2 where w = 1/[σ2(Fo2) + (aP)2 + bP]. 
 
Table 5-2. Selected bond distances (Å) and angles (°) in the cationic portion of 
4·2Et2O·3CH3CN a  
Ni(1)-O(1) 1.988(3) O(1)-Ni(1)-N(5) 106.66(13
Ni(1)-O(2) 2.057(3) N(3)-Ni(1)-N(5) 82.97(14)
Ni(1)-N(2) 2.119(3) O(2)-Ni(1)-N(5) 95.69(11)
Ni(1)-N(3) 2.039(3) N(2)-Ni(1)-N(5) 84.03(13)
Ni(1)-N(4) 2.341(3) O(1)-Ni(1)-N(4) 95.13(11)
Ni(1)-N(5) 2.188(3) N(3)-Ni(1)-N(4) 75.40(13)
Ni(2)-O(2) 1.864(2) O(2)-Ni(1)-N(4) 81.86(11)
Ni(2)-O(3) 1.856(3) N(2)-Ni(1)-N(4) 99.46(12)
  N(5)-Ni(1)-N(4) 157.36(13
O(1)-Ni(1)- 170.32(13 O(3)#1-Ni(2)- 175.39(18
O(1)-Ni(1)- 80.00(10) O(3)#1-Ni(2)- 94.20(11)
N(3)-Ni(1)- 100.27(12 O(3)-Ni(2)-O(2) 85.77(11)
O(1)-Ni(1)- 97.44(12) O(3)#1-Ni(2)-O(2)# 85.77(11)
N(3)-Ni(1)- 82.43(13) O(3)-Ni(2)- 94.19(11)
O(2)-Ni(1)- 177.24(13 O(2)-Ni(2)- 179.06(17
a Estimated standard deviations in the last significant figure are given in parentheses. 
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Figure 5-4. UV-vis spectrum of 4 in CH2Cl2 under a N2 atmosphere.  
 
 
Scheme 5-4. Exposure of an acetonitrile solution of 4 to O2. 
 
  
Figure 5-5. 1H NMR spectra of: (a) analytically pure 4; (b) the reaction mixture 
produced from treatment of 4 with O2; and (c) independently synthesized, analytically 
pure 5. 
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A drawing of the cationic portion of 5 is shown in Figure 5-6. Selected bond 
distances and angles of this cation are given in Table 5-3. Complex 5 exhibits κ3-
coordination of the 6-NA-6-Ph2TPA ligand, with the noncoordinated phenyl-appended 
pyridyl moiety serving as a hydrogen bond acceptor for a metal-bound water molecule. 
This hydrogen bonding interaction involves a N(5)…O(3) distance of 2.68 Å and a 
N(5)…H-O(3) angle of 172º. A similar hydrogen bonding interaction, involving a 
noncoordinated phenyl-appended phenyl nitrogen, was identified in a Ni(II) 
acetohydroxamic acid complex wherein the hydrogen bond donor is the N-H moiety of 
the Ni(II) bound acid.24 The Ni(1)-O(3) (water) distance in 5 is 2.061(3) Å, which is 
~0.03 Å shorter than the average of the other five metal ligand bond distances. The Ni(1)-
N(4) distance (2.137(3) Å) is on the short end of the range of bond lengths previously 
identified for a phenyl-appended pyridyl donor to a pseudo octahedral Ni(II) center 
(2.15-2.36 Å).22,23,27,30,37,38  The benzoate ligand is coordinated in a bidentate fashion, 
with the O(1) atom of the benzoate ligand accepting a hydrogen bond from 
neopentylamine moiety of the supporting chelate ligand.  
 In dry CD3CN 5 exhibits at least seven resonances in the range of 20-70 ppm 
(Figure 5-5(c)). As all three pyridyl donors are inequivalent in this complex, at least six 
resonances can be expected in this range for the β/β’-H’s (Figure 5-2). We note that 
methylene –CH2- resonances are also typically found in this region in mononuclear 
Ni(II)complexes of tripodal pyridyl ligands.30 In the reaction mixture produced upon 
treatment of 4 with O2 two additional products have been identified (Scheme 5-4). 
Exposure of a sample of the headspace gas of the reaction to an aqueous PdCl2 solution 
resulted in the deposition of Pd(0) which is consistent with presence of CO according to 
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Figure 5-6. Thermal ellipsoid drawing (50% probability) of the cationic portion of 5. 
Hydrogen atoms except the neopentylamine proton and the water protons have been 
omitted for clarity.   
 
Table 5-3. Selected bond distances (Å) and angles (°) in the cationic portion of 
5⋅CH3OH a 
Ni(1)-O(1) 2.075(3) O(3)-Ni(1)-N(4) 167.90(12
Ni(1)-O(2) 2.163(3) O(1)-Ni(1)-N(4) 95.29(11)
Ni(1)-O(3) 2.061(3) N(3)-Ni(1)-N(4) 79.62(12)
Ni(1)-N(2) 2.055(3) N(2)-Ni(1)-O(2) 170.31(11
Ni(1)-N(3) 2.099(3) O(3)-Ni(1)-O(2) 86.15(11)
Ni(1)-N(4) 2.137(3) O(1)-Ni(1)-O(2) 62.50(10)
  N(3)-Ni(1)-O(2) 107.23(11
N(2)-Ni(1)- 88.24(12) Ni(4)-Ni(1)- 83.73(11)
N(2)-Ni(1)- 109.23(11  
O(3)-Ni(1)- 85.86(11)  
N(2)-Ni(1)- 81.30(12)  
O(3)-Ni(1)- 97.14(12)  
O(1)-Ni(1)- 169.20(11  
N(2)-Ni(1)- 102.68(12  
a Estimated standard deviations in the last significant figure are given in parentheses. 
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the equation29: 
 
PdCl2 + CO + H2O → Pd0 + CO2 + 2 HCl 
 
A second product, benzil (PhC(O)C(O)Ph) was isolated from the reaction mixture 
via column chromatography on silica gel with hexanes/ethyl acetate (4:1) containing 
trace CH3CN as the eluent. This organic product has also been identified in the reactions 
of 1 as outlined in Scheme 5-2. The yield of benzil obtained in repeat reactions of 4 with 
O2 is ~20%.  
 The column chromatography separation method used to isolate benzil also 
enables the separation of 5 from another fraction that is yellow in color. Pure acetonitrile 
is used to elute 5 after which point the addition of methanol results in the elution of the 
yellow product. When dissolved in CD3CN the yellow material exhibits several broad 1H 
NMR resonances in the region of 5-8 ppm. In the portion of the spectrum from 7-8 ppm 
the broad resonances are overlapped with at least two smaller, sharper signals (~7.5 and 
8.0 ppm). The broad nature of the most intense resonances is consistent with a Ni(II)-
containing species. Infrared spectroscopic studies indicate that this material does not 
contain the 6-NA-6-Ph2TPA ligand or a perchlorate anion, but has vibrations indicating 
the presence of one or more benzoate anions. Specifically, carboxylate vibrations are 
present at 1554 (νas(COO-)) and 1405 cm-1 (νs(COO-)), respectively, and phenyl group 
vibrations at 1598 cm-1 and 717 cm-1. These vibrations are similar to the major vibrations 
of sodium benzoate (1598, 1550, 1414, 706, and 681 cm-1). Additional vibrations for the 
reaction product are found at ~3400 and ~2950 cm-1. We propose that these vibrations 
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may be due to the presence of methanol, suggesting a formulation such as 
Ni(O2CPh)2⋅nCH3OH. A Cambridge Crystallographic Database search revealed that a 
series of nickel benzoate complexes having monodentate carboxylate ligands and four 
coordinated water molecules of the empirical formula [Ni(O2CAr)2(H2O)4]⋅nH2O (Ar = 
3,5-dihydroxyphenyl (n = 3); 3,5-dinitrophenyl (n = 4); or 4-formylphenyl (n=4)) have 
been structurally characterized.40-42 However, X-ray quality crystals of the yellow 
product have not yet been obtained.  
Treatment of a CH3CN (ACROS extra dry, <10 ppm water) solution of 4 with 
18O2 results in ~86% 18O labelling of one oxygen atom of the benzoate ligand of 5. 
Reactions of this type performed using 16O2, extra dry CH3CN, and H218O did not result 
in 18O incorporation into 5. Thus, the ~14% of 5 that contains unlabeled benzoate must be 
generated from adventitious 16O2 in the reaction mixture or via an alternative reaction 
pathway.  
Comments on the O2 Reactivity of 1 and 4. In the absence of added base 1 
reacts with O2 to give a nickel benzoate complex, CO, benzil, and other phenyl-
containing organic products.23 This reaction occurs with only a modest level of 18O 
incorporation (~50%) into one oxygen atom position of the benzoate ligand of [(6-
Ph2TPA)Ni(O2CPh)]ClO4 (3). Under conditions wherein the dianionic enediolate form of 
2-hydroxy-1,3-diphenylpropane-1,3-dione is present, for example 1 upon treatment with 
base or in 4, the reaction is cleaner, with the only organic byproduct being benzil. These 
reactions also exhibit a higher level of 18O incorporation into one of the oxygen atom 
position in the product benzoate complex, [6-Ph2TPA)Ni(O2CPh)2(H2O)] (2, 67%) or [(6-
NA-6-Ph2TPA)Ni(O2CPh)(H2O)]ClO4 (5, 86%), respectively. We note that these levels 
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of 18O incorporation are near that reported for the Ni(II)-ARD catalyzed reaction 
(77.5%).43 
 
Conclusions 
 The presence of a secondary hydrogen bond donor in the 6-NA-6-Ph2TPA ligand 
produces chemistry involving Ni(II) and 2-hydroxy-1,3-diphenylpropane-1,3-dione in the 
presence of base that is distinctly different from that found for the 6-Ph2TPA chelate 
ligand. Specifically, use of the 6-NA-6-Ph2TPA ligand has enabled the formation and 
isolation of the trinuclear 4 which contains a coordinated enediolate form of 2-hydroxy-
1,3-diphenylpropane-1,3-dione. This indicates that the Ni(II) coordination chemistry of 
this acireductone-type ligand is strongly influenced by the nature of the supporting 
chelate  
ligand and secondary environment surrounding the metal center. As the key factor in 
determining Ni(II)-ARD versus Fe(II)-ARD’ type reactivity has been proposed to be the 
coordination mode of the acireductone, which is likely influenced by the secondary 
environment of the metal center, additional investigations of ligand secondary 
environment modifications are clearly warranted.  
Current efforts in our laboratory are also focused on kinetic and mechanistic 
studies of the O2 reactions involving 1 and 4. One avenue of investigation is directed at 
determining the pathway by which benzil is generated. We hypothesize that benzil may 
be formed via a reaction wherein the enolate or endiolate moiety of 1 or 4 is oxidized by 
O2 to give 1,3-diphenylpropanetrione (PhC(O)C(O)C(O)Ph) and hydroperoxide/peroxide 
anion.44 A phenyl migration reaction involving this triketone could yield benzil and CO.45 
As triketones have also been shown to undergo reaction with H2O2 to yield carboxylates 
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and CO,46 we hypothesize that the products generated in the reactions of 1 and 4 with O2 
could be generated via a “triketone” pathway or via a mechanism involving a Ni(II)-
coordinated cyclic peroxide species, as has been proposed for Ni(II)-ARD.1 Efforts are 
underway to determine if one or both of these types of reaction pathways are occurring 
upon treatment of 1 and 4 with O2.  
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CHAPTER 6 
A STRATEGY TOWARD PRODUCING A Ni(II) COMPLEX 
HAVING A C(1)-H ACIREDUCTONE LIGAND 
 
Abstract 
 In order to investigate chemistry of relevance to a Ni(II)-containing acireductone 
dioxygenase (ARD) enzyme, a new Ni(II) complex having a C(1)-H acireductone ligand 
has been prepared. The acireductone (2,3-dihydroxy-1-phenyl-propenone) used in this 
study is an analog of the native ARD substrate and can be obtained via a previously 
reported combined synthetic/enzymatic route. This method involves the convenient 
synthesis of the phosphate-protected precursor followed by an enolase/phosphatase (E1) 
catalyzed reaction. A His-tagged version of the E1 enzyme was used in this study, which 
significantly simplified the protein purification process. A monosodium salt of the C(1)-
H acireductone was generated via extraction of the enzymatic reaction mixture at low pH 
followed by a treatment of the isolated acireductone with NaOH.  Introduction of this 
acireductone salt into a CH3CN solution of [(6-Ph2TPA)Ni](ClO4)2 resulted in the 
formation of a new O2 sensitive complex which is formulated as [(6-
Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4  based on 1H NMR and UV-visible 
spectroscopic analyses. This complex reacts with O2 to produce a Ni(II) benzoate 
complex, [(6-Ph2TPA)Ni(O2CPh)]ClO4. The preliminary results presented in this chapter 
indicate that Ni(II) coordination of an acireductone influences the regioselectivity of the 
oxidative carbon-carbon bond cleavage reaction within the acireductone ligand.  
 
Introduction 
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 Compounds containing an acireductone functionality (α-keto enediol, 
RC(OH)=C(OH)C(=O)R’) are strong reducing agents and fairly strong acids (e.g. 
ascorbic acid).1 Furthermore, their anionic forms are electron rich and are susceptible to 
electrophilic attack by dioxygen.2  An acireductone (2,1,2-dihydroxy-3-oxo-5-
(methylthio)pent-1-ene) was identified as an advanced intermediate in the methionine 
salvage pathway (MSP) (Scheme 6-1).3 This ubiquitous pathway recycles the methylhio- 
portion of S-adenosylmethionine (SAM) to produce methionine.4 A breakdown of the 
ribose ring of methylthioadenosine (MTA) provides a carbon skeleton for the formation 
of the intermediate 1 (1-phosphonooxy-2,2-dihydroxy-3-oxo-5-methylhiopentane). 
Compound 1 is subsequently converted into acireductone 2 via the E1 
enolase/phosphatase catalyzed reaction.  
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Scheme 6-1. An outline of the methionine salvage pathway (MSP).  
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Figure 6-1. Analogs of the ARD substrate. 
 
To date, there has not been a synthetic route reported for the native -SMe 
containing acireductone substrate (2, Scheme 6-1). This is likely due to the presence of 
the -SMe substituent at the C(5) position, as this moiety is susceptible to oxidation and β-
elimination reactions.5 This problem was addressed by the Abeles group with the 
preparation of desthio analogs of the naturally occurring acireductone substrate (3 and 4, 
Figure 6-1).2 These compounds were shown to be alternative substrates for the ARD 
enzymes. However, the synthetic pathway reported by Abeles et al. gave relatively low 
overall yields and required the use of explosive diazomethane. In 2004, a combined 
synthetic/enzymatic approach for preparing 3 and 4 was reported by Pochapsky et al.6 
This method involves a convenient 3-step synthesis of the phosphate esters (Scheme 6-2) 
and their subsequent E1-catalyzed enolization/dephosphorylation reaction, which results 
in the formation of the desired acireductone. 
Our laboratory has previously reported the preparation of a Ni(II) complex of a 
mono-deprotonated form of 2-hydroxy-1,3-diphenylpropan-1,3-dione (5, Figure 6-2). 
This molecule contains an acireductone-type motif albeit it has not been shown to be an 
alternative substrate for Ni(II)- or Fe(II)-ARD. The Ni(II) complex reacts with O2 to 
produce carboxylates and CO, hence this reaction is relevant to the chemistry 
of Ni(II)-ARD. However, additional organic side products (e.g. benzil, PhC(O)C(O)Ph) 
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Figure 6-2. Ni(II) complex of a deprotonated form of 2-hydroxy-1,3-diphenylpropan-1,3-
dione.  
 
are generated in the O2-dependent reaction, suggesting that multiple reaction pathways 
may be operative in this system. Specifically, we hypothesize that the phenyl group at the 
C(1) position of the coordinated enolate enables a pathway involving triketone formation 
that is not relevant to the Ni(II)-ARD catalyzed reaction. 
In order to prepare a more accurate model complex for the enzyme/substrate 
adduct in Ni(II)-ARD, we have used the combined synthetic/enzymatic approach 
reported by Pochapsky to prepare the C(1)-H acireductone 3. Admixture of the 
monosodium salt of this acireductone with a Ni(II) complex of the 6-Ph2TPA ligand has 
resulted in the formation of a new Ni(II) acireductone complex 8. Its 1H NMR and UV-
visible spectroscopic properties are consistent with the formulation [(6-
Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4. This complex reacts with O2 to produce 9 [(6-
Ph2TPA)Ni(O2CPh)]ClO4 in a reaction that is relevant to Ni(II)-ARD enzyme reaction. 
Thus, a new reactive model system for Ni(II)-ARD involving a C(1)-H containing 
acireductone has been developed. 
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Experimental Section 
 General Methods. All reagents and solvents for synthetic procedures were 
obtained from commercial sources and were used as received without further purification 
unless otherwise noted. Solvents were dried according to published methods and distilled 
under N2 atmosphere prior to use.7 Water- and oxygen-sensitive reactions were performed 
in a M-20 Vacuum Atmosphere glovebox under an atmosphere of purified N2. The E1 
enolase/phosphatase coding plasmid (pDioxHIS1) was obtained from Prof. Wilson 
Francisco (Arizona State University) and was stored at -80 oC.  
 Physical Methods.  Diamagnetic 1H and 13C spectra were collected using a 
Bruker ARX-400 spectrometer. Paramagnetic 1H NMR spectra were recorded as 
previously described.8 UV-vis spectra of buffered solutions of 3 and a acetonitrile 
solution of 8 were recorded at ambient temperature using a Hewlett Packard 8453 diode 
array spectrophotometer.  
 Caution! Perchlorate salts of metal complexes with organic ligands are 
potentially explosive. Only small amounts of material should be prepared and these 
should be handled with great care.9 
 Synthesis of a Phosphate Ester Protected E1 Substrate Analog (6). The ester 
compound 1-phosphonooxy-2,2-dihydroxy-3-phenylpropane 6 was prepared according to 
the literature procedure.6 Its acidic, aqueous solutions were stored at -20 oC.   
 Overexpression and Purification of a His-tagged E1 Enolase/phosphatase 
Enzyme. Single colonies of E. coli (BL21) transformed with the pDioxHIS10 plasmid 
were selected from LB-agar plates supplemented with kanamycin and placed in 
kanamycin-supplemented LB media. Protein expression was induced upon addition of 
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isopropyl β-D-thioglucopuranoside (IPTG). Once cell density reached ~0.6 at 600 nm 
cells were harvested by centrifugation (10,000 x g, 10 min), the supernatant was 
discarded, and the remaining protein pellets stored at -20oC until purified. 
 Purification Procedure. Cell pellets were resuspended in 30 mL of 50 mM Tris 
buffer (pH 7.6) containing 500 mM NaCl. To this mixture 30 µL of a 1 mM iPrOH 
solution of phenylmethylsulfonyl fluoride (PMSF) was added in order to inhibit protease 
activity. A catalytic amount of DNases was then added and the cells were lysed by 
passing through a French Press. The lysate was cleared by centrifugation (10,000 x g, 10 
min) and the resulting pellets discarded. The E1 enzyme present in the supernatant was 
then purified using a Ni-affinity column. Following the introduction of a protein sample, 
the column was washed with ~30 mL of 50 mM Tris buffer (pH 7.6). The E1-containing 
fraction was eluted from the column using 15 mL of Tris buffer containing 500 mM 
imidazole. The E1 fractions were dialyzed overnight against 50 mM HEPES buffer 
containing 0.5 mM MgCl2 (replaced with fresh buffer solution twice). The purity of the 
E1 enzyme was confirmed by Coomassie-stained SDS-PAGE and was estimated to be 
~95 %. The enzyme was assayed for enolase/phophatase activity according to the 
literature procedure.6 Enzyme assays were performed under N2 atmosphere. The obtained 
E1 enzyme exhibited ~ 53 % of reported previously activity level. A buffered E1 enzyme 
solution was stored at 8 oC.  
 Sodium 2-hydroxy-3-oxo-3-phenyl-propen-1-olate (7). An aqueous solution of 
the phosphate ester-protected acireductone precursor 1-phosphonooxy-2,2-dihydroxy-3-
phenylpropane (6, ~200 mg) was brought to pH 7-8 using 1 M NaOH solution. This 
solution was then diluted to ~200 ml with 50 mM HEPES buffer, containing 0.5 mM 
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MgCl2 (pH 7.4) and degassed. It was combined with 20 ml of E1/HEPES buffer solution 
(50 mM, pH 7.4) under an inert atmosphere. The reaction to produce acireductone was 
monitored by UV-visible spectroscopy by placing 1 drop of the reaction mixture into 2 
ml of 50 mM HEPES buffer at pH 7.4 in an anaerobic cuvette. Completion of the reaction 
was indicated by a single, absorption band at 320 nm. The enzyme solution was then 
brought to pH ~1 using 6 M HCl (~5 mL) and was extracted with CH2Cl2 (4 x 30 ml) 
under a N2 atmosphere. The organic fractions were combined and solvent was removed 
under vacuum. The presence of the acireductone product in the solid residue was 
confirmed by UV-visible spectroscopy by dissolving a minimal amount of the solid (~1 
mg) in 2 ml of 50 mM HEPES buffer at pH 7.4 under anaerobic conditions. The purity of 
the extracted acireductone sample (~90%) was established using 1H NMR. (3) 1H NMR 
(CD3CN, 400 MHz) δ 7.58-7.52 (m, 3 H), δ 7.47-7.43 (m, 2 H), δ 7.11 (br, 1 H). The 
remaining solid product was then dissolved in distilled H2O under a N2 atmosphere and 
the pH of the solution was adjusted to ~8-9 using 0.1 M NaOH. Removal of water under 
vacuum yielded a yellow-orange material (0.055g, 36% yield). (7) 1H NMR (CD3OD, 
400 MHz) δ 8.07 (s, 1H), δ 7.45-7.43 (m, 2 H), δ 7.38-7.33 (m, 3 H). UV-vis (7.4 HEPES 
buffer), nm (λmax, M-1cm-1): 320 (8000).  
 [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4 (8). Equimolar amounts of 6-
Ph2TPA (0.0313 g, 0.0714 mmol) and Ni(ClO4)2•6H2O (0.0261 g, 0.0714 mmol) were 
dissolved in ~ 2 mL of CH3CN under a N2 atmosphere. This mixture was then combined 
with a methanol solution of sodium 2-hydroxy-3-oxo-3-phenyl-propen-1-olate 7 (0.0133 
g, 0.0714 mmol) and the resulting orange solution was stirred under a N2 atmosphere for 
~40 min. Analysis of the reaction mixture using UV-visible spectroscopy (in CH3CN) 
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indicated the formation of new O2 sensitive species with λmax = 378 nm. An aliquot of the 
reaction mixture was then dried under reduced pressure and was subsequently dissolved 
in CD3CN for a 1H NMR experiment. This analysis revealed the formation of one major 
Ni(II) complex product. This compound has β/β’ pyridyl ring proton resonances at 46.6, 
41.4, 43.2, and 33.4 ppm. The overall mixture was then brought to dryness under vacuum 
and the remaining orange/brown residue was dissolved in CH2Cl2, filtered, and the 
solvent was again removed under reduced pressure. Attempts to crystallize the product 
have not yet yielded crystals suitable for single crystal X-ray diffraction. 
 O2 Reactivity of [(Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4 (8). Isolation and 
Identification of the Major Ni(II)-containing Product (9). The proposed Ni(II) 
acireductone complex [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4 8 (~10 mg) was 
dissolved in CH3CN (~2 ml) resulting in the formation of a deep orange solution. Upon 
exposure of this solution to air, bleaching of the orange color occurred and the resulting 
yellow mixture was stirred for several hours at ambient temperature. Removal of the 
solvent under reduced pressure yielded a yellow solid material. This crude product was 
recrystallized via Et2O diffusion into a CH3CN/MeOH solution to give a blue crystalline 
material. 1H NMR analysis of this product revealed the formation of 9 ([(6-
Ph2TPA)Ni(O2CPh)]ClO4) as indicated by a distinct set of β/β’ pyridyl-ring proton 
resonances in the range of 30-50 ppm. This compound has been previously isolated and 
fully characterized.10 The proposal of [(6-Ph2TPA)Ni(O2CPh)]ClO4 as the reaction 
product is further supported by mass spectrometry analysis of the sample which 
confirmed the presence of the [(6-Ph2TPA)Ni(O2CPh)]+ ion. 
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Results and Discussion 
 Synthesis of an E1 Substrate Analog (6). The phosphate ester protected 
precursor 6 was synthesized according to the literature procedure.6 The synthetic 
pathway, as well as percent yields is shown in Scheme 6-2. Compound 6 was isolated 
from the reaction mixture under acidic conditions and was stored as an aqueous solution 
at -20 °C. This compound was then used as a substrate analog for the E1 
(enolase/phosphatase) enzyme (Scheme 6-3). 
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Scheme 6-2. A synthetic pathway for the enolase/phosphatase (E1) substrate analog 6. 
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Scheme 6-3. Enzymatic activity of enolase/phosphatase (E1) with the substrate analog 6. 
 
Overexpression and Purification of a His-tagged E1 Enolase/phosphatase Enzyme. 
The E1 enolase/phosphatase encoding plasmid (pDioxHIS1) was kindly provided to us 
by Professor Wilson Francisco (Arizona State University). This plasmid was modified by 
incorporating a new NdeI site into the start codon for the E1 gene to improve expression. 
The resulting construct was reinserted into pEt30a to give the plasmid pDioxHIS10. 
Overexpression of this His-tagged vector in E. coli (BL21) resulted in production of the 
desired E1 enolase/phosphatase enzyme. This enzyme was purified using a Ni-affinity 
column and showed activity with the Ph-containing E1 substrate analog 1 (Scheme 6-3). 
An enzymatic activity assay of the E1 enolase/phosphatase enzyme was performed 
anaerobically following the literature procedure.6 This reaction is conveniently monitored 
using UV-visible spectroscopy, as the acireductone product has a characteristic 
absorption maximum at 320 nm. This reaction proceeds with a transient build-up of an 
enol-phosphate intermediate that can be observed spectroscopically at 278 nm (Scheme 
6-3). Although, the observed level of E1 activity was only ~50% of that reported for the 
non-His tagged enzyme this level of activity appears to be sufficient for our synthetic 
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purposes.6 Under these conditions (HEPES buffer, pH 7.4) the C(1)-H acireductone is 
produced as a monoanion which is highly O2 sensitive. As shown in Figure 6-3, 
spontaneous decomposition of this monoanion in the presence of O2 results in the 
disappearance of its characteristic absorption band at 320 nm and subsequent formation 
of a band at 252 nm, which is assigned to the α-keto acid product. 
 Isolation of the Phenyl Acireductone Monoanion Salt Sodium 2,3-Dihydroxy-
1-phenyl-propenoate (7). This procedure initially involves monitoring the E1 reaction 
mixture to determine whether the conversion of 1 to acireductone is complete (Scheme 6-
3). Acidification of the reaction mixture to pH ~1 under N2, followed by extraction with 
CH2Cl2 enabled the isolation of the acireductone product. Treatment of this product with 
NaOH solution resulted in its conversion into the monosodium salt. 
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Figure 6-3. Reaction that takes place between the 3 and O2 at pH 7.4 (top). 
Disappearance of the absorption band at 320 nm for 3 and appearance of an absorption 
feature at 252 nm for the α-keto acid product (bottom). 
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This overall procedure enables the routine isolation of ~50 mg of the acireductone salt. 
Additional efforts to optimize this procedure are in progress. 
 Synthesis of [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)H]ClO4 (8). The 6-Ph2TPA 
supporting chelate has been used previously to produce a Ni(II) cis-β-keto-enolate 
complex, [(6-Ph2TPA)Ni-(PhC(O)C(OH)C(O)Ph)]ClO4 (5, Figure 6-2). This complex is 
relevant to the enzyme/substrate adduct in Ni(II)-ARD.11 The work outlined herein 
describes the preparation of a new Ni(II)-acireductone complex using this supporting 
chelate ligand and acireductone 3. Under a nitrogen atmosphere, equimolar amounts of 6-
Ph2TPA and Ni(ClO4)2·6 H2O in acetonitrile were combined with a methanol solution of 
sodium 2-hydroxy-3-oxo-3-phenyl-propen-1-olate (7). 1H NMR and UV-vis analyses of 
obtained orange solution indicated the formation of a new 6-Ph2TPA-supported Ni(II) 
acireductone complex (8, Scheme 6-5). As shown in Figure 6-4, the 30-60 ppm, region of 
the 1H NMR spectrum of this complex is similar to that exhibited by [(6-
Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (5) . These paramagnetically shifted resonances 
are assigned to β/β’ pyridyl ring protons of the chelate ligand. The resemblance of the 
observed patterns indicates similar overall mirror plane symmetry (equivalent phenyl 
pyridyl appendages). The UV-vis spectrum of the new complex 8 contains a broad 
absorption band at 378 nm (CH3CN solution; Figure 6-5). This spectrum is notably 
distinct from that exhibited by a non-coordinated 2-hydroxy-3-oxo-3-phenyl-propen-1-
olate monoanion (λmax = 320 nm, pH = 7.4 (HEPES buffer)).6 On the basis of these initial 
results, we formulate 8 as [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4. Additional 
experiments (FTIR, EA) are planned to further characterize this complex. We are also 
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attempting to recrystallize 8 and efforts thus far have yielded crystalline materials, albeit 
not X-ray quality crystals.  
 Exposure of a CH3CN solution of 8 to the air results in a gradual loss of the 378 
nm absorption band (Figure 6-5). Examination of the reaction products by 1H NMR and 
mass spectrometry revealed the production of a single Ni(II) compound, the benzoate 
derivative [(6-Ph2TPA)Ni(O2CPh)]ClO4 (9). This compound has been previously isolated 
and fully characterized.10 A comparison of the 1H NMR features of the reaction product 
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Scheme 6-4. The isolation of C(1)-H acireductone from the E1 reaction mixture followed 
by the conversion of the acireductone product into its sodium salt. 
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Scheme 6-5. Synthetic procedure for the preparation of 8. 
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Figure 6-4. Comparison of a region of the 1H NMR spectra of the 6-Ph2TPA-supported 
Ni(II) acireductone complexes [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 5 (top) and 8 
(bottom). 
 
 
 
 
 
 
 
 
Figure 6-5. Electronic absorption spectra of 8 ([(6-
Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4). Disappearance of the absorption maximum at 
378 nm represents the oxygen-dependent reaction. 
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Figure 6-6. Paramagnetically shifted 1H NMR resonances of [(6-
Ph2TPA)Ni(O2CPh)]ClO4; region of 20-70 ppm (top). 1H NMR spectrum of the product, 
resulting from the oxidative decomposition of [(6- 
Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4 (9) (bottom). 
 
of 8 upon treatment with O2 and those of 5 is shown in Figure 6-6. The formation of 9 is 
notable, as it indicates that the reaction of 8 with O2 gives different products than the 
reaction of the acireductone monoanion 3 with O2 (Figure 6-3). This means that 
coordination to the metal center affects the regioselectivity of the oxidative carbon-
carbon bond cleavage reaction. Further studies to characterize the reaction of 8 with O2 
are in progress. These include efforts to identify formic acid and CO as products of the 
reaction.  
 
Conclusions 
 A new synthetic methodology has been investigated for the preparation of Ni(II) 
acireductone complexes using an acireductone that can serve as an alternative substrate 
for Ni(II)-ARD. Initial indications are that we will be able to isolate and characterize a 
new acireductone complex and explore in detail its reactivity with O2.  
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CHAPTER 7 
CONCLUSIONS 
 The work presented in this dissertation summarizes our efforts to investigate the 
structural, spectroscopic, and reactivity properties of Ni(II) complexes with biologically 
relevant compounds. These complexes are model systems of relevance to the properties 
of redox inactive Ni(II)-containing enzymes. Among nickel-containing metalloenzymes 
there are only three examples known to date in which nickel exhibits no redox activity, 
namely urease, glyoxalase I, and acireductone dioxygenase. The active sites of these 
enzymes contain Ni(II) ion(s) ligated by N/O-donor amino acid residues and water 
molecules in a common pseudo octahedral geometry. 
 The anion of acetohydroxamic acid (Figure 7-1, (A)) is a well known competitive 
inhibitor of urease enzymes. The mechanism of inhibition is proposed to involve the 
initial formation of a weak enzyme/inhibitor complex with acetohydroxamic acid to one 
of the two Ni(II) centers. This complex is then suggested to undergo dehydration to form 
the acetohydroxamate inhibited species. However, this hypothesis is based solely on 
kinetic investigations of the inhibition reaction and there was no structural evidence to 
support this proposal. 
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Figure 7-1. Acetohydroxamic acid (A); hemithioacetal (B); acireductone (C) 
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  In order to more fully understand the inhibition mechanism in urease, we 
investigated the chemistry of a mononuclear Ni(II) complex supported by a N/O-donor 
chelate ligand. Treatment of this complex with an equimolar amount of acetohydroxamic 
acid (AHA) resulted in the formation of a novel pseudo-octahedral Ni(II)-AHA complex. 
Interestingly, binding of AHA to the nickel center was supported by a hydrogen-bonding 
interaction with a hemi-labile pyridyl arm of the chelate ligand. Prior to our report of this 
unique structure, there were no examples of this type of neutral AHA coordination to any 
transition metal complex. We also demonstrated that the observed hydrogen-bonding 
interaction was essential in stabilizing AHA coordination. Addition of water to a solution 
of the AHA-containing Ni(II) complex disrupted the H-bonding thereby causing the 
release of this ligand from the metal center. This chemical model provides precedent for 
the feasibility of a weak enzyme/inhibitor complex of AHA in urease. 
 Nickel-containing glyoxalase I is another example of an enzyme in which a Ni(II) 
center is redox inactive. Glyoxalase I (GlxI) is involved in a cellular detoxification 
process and catalyzes the isomerization of a hemithioacetal to a thioester (the general 
structure of a hemithioacetal is shown in Figure 7-1 (B)). The precise function of a nickel 
center in this catalytic reaction is still under debate, although one of the proposed 
mechanisms suggests the formation of a Ni(II)-OH species. This hydroxide species is 
suggested to play the role of a general base in the catalytic process.  
 Our goal was to create a synthetic system that could promote hemithioacetal 
isomerization. Although, we did not succeed in the synthesis of a hydroxide-containing 
Ni(II) complex, we were able to prepare a Ni(II) complex having an anionic chelate 
ligand. This complex was shown to promote a hemithioacetal isomerization reaction in a 
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fashion akin to that proposed in the enzymatic system. Prior to our report there was no 
precedent in the literature of a well-defined coordination compound that is able to 
promote the isomerization of a hemithioacetal. Spectroscopic monitoring of this reaction 
led us to propose that the enediolate intermediate that is generated by proton abstraction 
likely does not interact with Ni(II) center.  
 The role of Ni(II) in the glyoxalase I-catalyzed isomerization is also intriguing for 
another reason. Recent studies revealed that the Ni(II)-containing form of GlxI is 
significantly less abundant than its Zn(II)-activated analog. Specifically, there are very 
few examples of bacterial GlxI enzymes that are activated by Ni(II) ions. However, the 
Ni(II)-containing GlxI enzyme isolated from E. coli displays an interesting propensity 
toward Ni(II) activation and lose activity when the nickel ion is replaced by Zn(II) in the 
active site. Investigation of the Ni(II) role in GlxI  might serve as a basis to address 
questions concerning how protein structure might influence selectivity for a particular 
metal ion versus another in the same catalytic reaction. This question can also be probed 
through synthetic modeling studies. The most intuitive approach would be to synthesize a 
Zn(II) analog of our previously reported functional Ni(II) model complex and study its 
reactivity toward a hemithioacetal. 
 Acireductone dioxygenase (ARD) is a less studied example of a Ni(II)-containing 
redox inactive enzyme. However, the role of Ni(II) in its catalytic reaction is very 
interesting. ARD enzymes (Ni(II)- and Fe(II)-containing) are associated with the 
methionine salvage pathway (MSP), a ubiquitous biological cycle. These enzymes 
catalyze aliphatic oxidative C-C bond cleavage in an acireductone (1,2-dihydroxy-3-oxo-
5-(methylthio)pent-1-ene) intermediate. A unique feature of these enzymes is that the 
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regioselectivity of the dioxygenase reaction depends on the metal ion bound in the active 
site. A mechanistic pathway for the reactions catalyzed by these enzymes have been 
proposed, but not yet rigorously evaluated.  
 Our approach toward evaluating the Ni(II)-ARD mechanism involves the 
synthesis of Ni(II) complexes having acireductone ligands coordinated to the metal 
center, reminiscent of the anaerobic enzyme/substrate complex in ARD. Scheme 7-1 (C) 
shows the general structure of an acireductone. Using an appropriate N4-donor chelate 
ligand we have prepared and fully characterized a functional model complex relevant to 
Ni(II)-containing ARD. This novel trinuclear complex, formulated as [(6-NA-6-
Ph2TPANi)2(µ-PhC(O)C(O)C(O)Ph)2Ni](ClO4)2, contains a doubly deprotonated form of 
the acireductone coordinated to the metal center. Two of the Ni(II) centers are pseudo 
octahedral and they are supported by the chelate ligand whereas the third square planar 
Ni(II) ion (central) is ligated by two acireductone molecules. This complex has been 
proven to react with O2 resulting in the formation of carboxylate products and CO, which 
is relevant to the reaction catalyzed by Ni(II)-containing ARD. Analysis of the reaction 
mixture revealed also the presence of benzil (PhC(O)C(O)Ph), indicating that an 
alternative reaction pathways may be operative in this system. 
 In efforts to further elucidate the oxygen reactivity of Ni(II)-coordinated 
acireductones, we have attempted the preparation of a new Ni(II) complex having a C(1)-
H acireductone ligand, an analog of the native Ni(II)-ARD substrate. 1H NMR and UV-
visible spectroscopic properties of  this new species are consistent with the formulation of 
[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)H)]ClO4. This complex reacts with O2 to produce [(6-
Ph2TPA)Ni(O2CPh)]ClO4 , which was confirmed spectroscopically. This new functional 
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model complex requires further characterization, specifically X-ray crystallographic and 
elemental analyses in order to confirm the proposed formulation. The formation of the 
carboxylate-containing Ni(II) complex upon the reaction with oxygen is indicative of the 
an ARD-relevant pathway. However, additional experiments need to be performed in 
order to prove our hypothesis, such as CO detection and analysis of the organic 
byproducts in the reaction mixture. Furthermore, if this model system is proven to be 
truly functional, the synthesis of its iron analog would be very advantageous. Analysis of 
the structural properties and the oxygen reactivity of the iron analog might provide 
insight into the chemistry of ARD system, wherein Ni(II)-ARD and Fe(II)-ARD catalyze 
distinct oxidation reactions.  
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